Interleukin-10	B-protein
inhibits	O
expression	O
of	O
both	O
interferon	B-DNA
alpha-	I-DNA
and	I-DNA
interferon	I-DNA
gamma-	I-DNA
induced	I-DNA
genes	I-DNA
by	O
suppressing	O
tyrosine	O
phosphorylation	O
of	O
STAT1	B-protein
.	O

Interleukin-10	B-protein
(	O
IL-10	B-protein
)	O
helps	O
maintain	O
polarized	B-cell_type
T-helper	I-cell_type
cells	I-cell_type
in	O
a	O
T-helper	B-cell_type
lymphocyte	I-cell_type
2	I-cell_type
(	I-cell_type
Th2	I-cell_type
)	I-cell_type
phenotype	I-cell_type
.	O

Part	O
of	O
this	O
process	O
involves	O
the	O
prevention	O
of	O
the	O
development	O
of	O
Th1	B-cell_type
cells	I-cell_type
,	O
which	O
are	O
a	O
primary	O
source	O
of	O
interferon	B-protein
gamma	I-protein
(	O
IFNgamma	B-protein
)	O
,	O
a	O
potent	O
activator	O
of	O
monocytes	B-cell_type
and	O
an	O
inhibitor	O
of	O
Th2	O
proliferation	O
.	O

Because	O
monocytes	B-cell_type
and	O
macrophages	O
are	O
important	O
mediators	O
of	O
Th1-type	O
responses	O
,	O
such	O
as	O
delayed-type	O
hypersensitivity	O
,	O
we	O
sought	O
to	O
determine	O
if	O
IL-10	B-protein
could	O
directly	O
mediate	O
inhibition	O
of	O
IFNgamma-	O
and	O
IFNalpha-induced	O
gene	O
expression	O
in	O
these	O
cells	O
.	O

Highly	O
purified	O
monocytes	B-cell_type
were	O
incubated	O
with	O
IL-10	B-protein
for	O
60	O
to	O
90	O
minutes	O
before	O
the	O
addition	O
of	O
IFNgamma	B-protein
or	O
IFNalpha	B-protein
.	O

IL-10	B-protein
preincubation	O
resulted	O
in	O
the	O
inhibition	O
of	O
gene	O
expression	O
for	O
several	O
IFN-induced	B-DNA
genes	I-DNA
,	O
such	O
as	O
IP-10	B-protein
,	O
ISG54	B-protein
,	O
and	O
intercellular	B-protein
adhesion	I-protein
molecule-1	I-protein
.	O

The	O
reduction	O
in	O
gene	O
expression	O
resulted	O
from	O
the	O
ability	O
of	O
IL-10	B-protein
to	O
suppress	O
IFN	B-protein
-induced	O
assembly	O
of	O
signal	B-protein
transducer	I-protein
and	I-protein
activator	I-protein
of	I-protein
transcription	I-protein
(	I-protein
STAT	I-protein
)	I-protein
factors	I-protein
to	O
specific	B-DNA
promoter	I-DNA
motifs	I-DNA
on	O
IFNalpha-	B-DNA
and	I-DNA
IFNgamma-inducible	I-DNA
genes	I-DNA
.	O

This	O
was	O
accomplished	O
by	O
preventing	O
the	O
IFN-induced	O
tyrosine	O
phosphorylation	O
of	O
STAT1	B-protein
,	O
a	O
component	O
of	O
both	O
IFNalpha-	B-protein
and	I-protein
IFNgamma-induced	I-protein
DNA	I-protein
binding	I-protein
complexes	I-protein
.	O

Therefore	O
,	O
IL-10	B-protein
can	O
directly	O
inhibit	O
STAT-dependent	B-DNA
early	I-DNA
response	I-DNA
gene	I-DNA
expression	O
induced	O
by	O
both	O
IFNalpha	B-protein
and	O
IFNgamma	B-protein
in	O
monocytes	B-cell_type
by	O
suppressing	O
the	O
tyrosine	O
phosphorylation	O
of	O
STAT1	B-protein
.	O

This	O
may	O
occur	O
through	O
the	O
ability	O
of	O
IL-10	B-protein
to	O
induce	O
expression	O
of	O
the	O
gene	O
,	O
suppressor	O
of	O
cytokine	B-protein
signaling	I-protein
3	I-protein
(	O
SOCS3	B-protein
)	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

FOCUS	NULL
ON	NULL
HEMATOLOGY	NULL
Interleukin-10	NULL
Inhibits	NULL
Expression	NULL
of	NULL
Both	NULL
Interferon	NULL
a-	NULL
and	NULL
Interferon	NULL
y-Induced	NULL
Genes	NULL
by	NULL
Suppressing	NULL
Tyrosine	NULL
Phosphorylation	NULL
of	NULL
STAT1	NULL
By	NULL
Satoshi	NULL
Ito	NULL
,	NULL
Parsw	NULL
a	NULL
Ansari	NULL
,	NULL
Minoru	NULL
Sakatsume	NULL
,	NULL
Harold	NULL
Dickensheets	NULL
,	NULL
Nancy	NULL
Vazquez	NULL
,	NULL
Raymond	NULL
P.	NULL
Donnelly	NULL
,	NULL
Andrew	NULL
C.	NULL
Larner	NULL
,	NULL
and	NULL
David	NULL
S.	NULL
Finbloom	NULL
Interleukin-10	NULL
(	NULL
IL-10	NULL
)	NULL
helps	NULL
maintain	NULL
polarized	NULL
T-helper	NULL
cells	NULL
in	NULL
a	NULL
T-helper	NULL
lymphocyte	NULL
2	NULL
(	NULL
Th2	NULL
)	NULL
phenotype	NULL
.	NULL

Part	NULL
of	NULL
this	NULL
process	NULL
involves	NULL
the	NULL
prevention	NULL
of	NULL
the	NULL
development	NULL
of	NULL
Th1	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
a	NULL
primary	NULL
source	NULL
of	NULL
interferon	NULL
y	NULL
(	NULL
IFNy	NULL
)	NULL
,	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
monocytes	NULL
and	NULL
an	NULL
inhibitor	NULL
of	NULL
Th2	NULL
proliferation	NULL
.	NULL

Because	NULL
monocytes	NULL
and	NULL
macrophages	NULL
are	NULL
important	NULL
mediators	NULL
of	NULL
Th1-type	NULL
responses	NULL
,	NULL
such	NULL
as	NULL
delayed-type	NULL
hypersensitivity	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
determine	NULL
if	NULL
IL-10	NULL
could	NULL
directly	NULL
mediate	NULL
inhibition	NULL
of	NULL
IFNy-	NULL
and	NULL
IFN	NULL
«	NULL
-induced	NULL
gene	NULL
expression	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Highly	NULL
purified	NULL
monocytes	NULL
were	NULL
incubated	NULL
with	NULL
IL-10	NULL
for	NULL
60	NULL
to	NULL
90	NULL
minutes	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
IFNy	NULL
or	NULL
IFN	NULL
«	NULL
.	NULL

IL-10	NULL
preincubation	NULL
resulted	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
gene	NULL
expression	NULL
for	NULL
several	NULL
IFN-induced	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
IP-10	NULL
,	NULL
ISG54	NULL
,	NULL
and	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
.	NULL

The	NULL
NTERFERON	NULL
a	NULL
(	NULL
IFNa	NULL
)	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
therapeutically	NULL
effective	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
certain	NULL
types	NULL
of	NULL
leukemias	NULL
and	NULL
lymphomas	NULL
!	NULL

and	NULL
in	NULL
some	NULL
solid	NULL
tumors	NULL
such	NULL
as	NULL
melanoma	NULL
.	NULL
``	NULL

Although	NULL
not	NULL
used	NULL
as	NULL
frequently	NULL
as	NULL
IFN	NULL
,	NULL
IFNy	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
some	NULL
activity	NULL
in	NULL
renal	NULL
cell	NULL
carcinoma	NULL
and	NULL
is	NULL
a	NULL
major	NULL
secretory	NULL
product	NULL
of	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
interleukin-12	NULL
(	NULL
IL-12	NULL
)	NULL
.4	NULL
Obviously	NULL
,	NULL
not	NULL
all	NULL
tumors	NULL
respond	NULL
to	NULL
IFNs	NULL
,	NULL
and	NULL
the	NULL
effects	NULL
of	NULL
IFNs	NULL
on	NULL
cells	NULL
can	NULL
be	NULL
modulated	NULL
by	NULL
many	NULL
different	NULL
agents	NULL
.	NULL

A	NULL
cytoplasmic	NULL
protein	NULL
is	NULL
present	NULL
in	NULL
tumor	NULL
cells	NULL
that	NULL
can	NULL
block	NULL
the	NULL
formation	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
that	NULL
recognize	NULL
the	NULL
IFN-stimulated	NULL
response	NULL
element	NULL
of	NULL
IFN-induced	NULL
genes	NULL
.	NULL
``	NULL

T-cell	NULL
cytokines	NULL
such	NULL
as	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
can	NULL
also	NULL
effectively	NULL
block	NULL
the	NULL
ability	NULL
of	NULL
IFNs	NULL
to	NULL
activate	NULL
monocytes	NULL
,	NULL
cells	NULL
known	NULL
for	NULL
their	NULL
ability	NULL
to	NULL
mediate	NULL
cytotoxic	NULL
effects	NULL
against	NULL
tumor	NULL
cells	NULL
.	NULL
``	NULL

Therefore	NULL
,	NULL
the	NULL
effects	NULL
that	NULL
monocytes	NULL
exert	NULL
in	NULL
any	NULL
environment	NULL
depend	NULL
to	NULL
a	NULL
large	NULL
extent	NULL
on	NULL
the	NULL
type	NULL
of	NULL
T-cell	NULL
cytokines	NULL
present	NULL
at	NULL
the	NULL
time	NULL
they	NULL
interact	NULL
with	NULL
other	NULL
cells	NULL
.	NULL

Immune	NULL
responses	NULL
mediated	NULL
by	NULL
monocytes	NULL
and	NULL
activated	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
divided	NULL
into	NULL
two	NULL
types	NULL
,	NULL
based	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
groups	NULL
of	NULL
T-cell-derived	NULL
cytokines	NULL
.	NULL
``	NULL

Although	NULL
most	NULL
clearly	NULL
defined	NULL
in	NULL
murine	NULL
models	NULL
of	NULL
parasitic	NULL
diseases	NULL
,	NULL
such	NULL
as	NULL
Leish-mania	NULL
,	NULL
``	NULL
the	NULL
ability	NULL
to	NULL
classify	NULL
certain	NULL
human	NULL
diseases	NULL
into	NULL
one	NULL
From	NULL
Division	NULL
of	NULL
Cytokine	NULL
Biology	NULL
,	NULL
Center	NULL
for	NULL
Biologics	NULL
Evaluation	NULL
and	NULL
Research	NULL
,	NULL
Food	NULL
and	NULL
Drug	NULL
Administration	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
.	NULL

Submitted	NULL
May	NULL
11	NULL
,	NULL
1998	NULL
;	NULL
accepted	NULL
October	NULL
12	NULL
,	NULL
1998	NULL
.	NULL

Supported	NULL
by	NULL
the	NULL
Oak	NULL
Ridge	NULL
Institute	NULL
for	NULL
Science	NULL
and	NULL
Education	NULL
through	NULL
an	NULL
interagency	NULL
agreement	NULL
between	NULL
the	NULL
Department	NULL
of	NULL
Energy	NULL
and	NULL
the	NULL
FDA	NULL
(	NULL
S.1	NULL
.	NULL

,	NULL
H.D	NULL
.	NULL

,	NULL
and	NULL
N.V.	NULL
)	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
David	NULL
S.	NULL
Finbloom	NULL
,	NULL
MD	NULL
,	NULL
Division	NULL
of	NULL
Cytokine	NULL
Biology	NULL
,	NULL
Center	NULL
for	NULL
Biologics	NULL
Evaluation	NULL
and	NULL
Research	NULL
,	NULL
Food	NULL
and	NULL
Drug	NULL
Administration	NULL
,	NULL
29	NULL
Lincoln	NULL
Dr	NULL
(	NULL
Bldg	NULL
29A	NULL
,	NULL
Room	NULL
2D20	NULL
)	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892-4555	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

This	NULL
is	NULL
a	NULL
US	NULL
government	NULL
work	NULL
.	NULL

There	NULL
are	NULL
no	NULL
restrictions	NULL
on	NULL
its	NULL
use	NULL
.	NULL

0006-4971/99/9305-0120	NULL
$	NULL
0.00/0	NULL
1456	NULL
reduction	NULL
in	NULL
gene	NULL
expression	NULL
resulted	NULL
from	NULL
the	NULL
ability	NULL
of	NULL
IL-10	NULL
to	NULL
suppress	NULL
IFN-induced	NULL
assembly	NULL
of	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
factors	NULL
to	NULL
specific	NULL
promoter	NULL
motifs	NULL
on	NULL
IFN	NULL
«	NULL
&	NULL
-	NULL
and	NULL
IFNy-inducible	NULL
genes	NULL
.	NULL

This	NULL
was	NULL
accomplished	NULL
by	NULL
preventing	NULL
the	NULL
IFN-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
,	NULL
a	NULL
component	NULL
of	NULL
both	NULL
IFN	NULL
«	NULL
-	NULL
and	NULL
IFNy-induced	NULL
DNA	NULL
binding	NULL
complexes	NULL
.	NULL

Therefore	NULL
,	NULL
IL-10	NULL
can	NULL
directly	NULL
inhibit	NULL
STAT-dependent	NULL
early	NULL
response	NULL
gene	NULL
expression	NULL
induced	NULL
by	NULL
both	NULL
IFN	NULL
«	NULL
and	NULL
IFNy	NULL
in	NULL
monocytes	NULL
by	NULL
suppressing	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
.	NULL

This	NULL
may	NULL
occur	NULL
through	NULL
the	NULL
ability	NULL
of	NULL
IL-10	NULL
to	NULL
induce	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
,	NULL
suppressor	NULL
of	NULL
cytokine	NULL
signaling	NULL
3	NULL
(	NULL
SOCS3	NULL
)	NULL
.	NULL

This	NULL
is	NULL
a	NULL
US	NULL
government	NULL
work	NULL
.	NULL

There	NULL
are	NULL
no	NULL
restrictions	NULL
on	NULL
its	NULL
use	NULL
.	NULL

polarized	NULL
type	NULL
or	NULL
another	NULL
is	NULL
a	NULL
useful	NULL
tool	NULL
to	NULL
learn	NULL
more	NULL
regarding	NULL
the	NULL
immunologic	NULL
basis	NULL
of	NULL
that	NULL
particular	NULL
disease	NULL
.	NULL

A	NULL
cellular	NULL
immune	NULL
response	NULL
dominated	NULL
by	NULL
a	NULL
T-helper	NULL
lymphocyte	NULL
1	NULL
(	NULL
Th1	NULL
)	NULL
infiltration	NULL
,	NULL
in	NULL
which	NULL
IFNy	NULL
and	NULL
IL-2	NULL
predominate	NULL
,	NULL
is	NULL
observed	NULL
in	NULL
diseases	NULL
such	NULL
as	NULL
rheumatoid	NULL
arthritis®	NULL
or	NULL
inflammatory	NULL
bowel	NULL
disease	NULL
.	NULL
``	NULL

''	NULL
This	NULL
response	NULL
generally	NULL
evokes	NULL
a	NULL
delayed-type	NULL
hypersensitivity	NULL
reaction	NULL
.	NULL

Immune	NULL
responses	NULL
regulated	NULL
by	NULL
T-helper	NULL
lymphocyte	NULL
2	NULL
(	NULL
Th2	NULL
)	NULL
cells	NULL
result	NULL
in	NULL
the	NULL
secretion	NULL
of	NULL
IL-4	NULL
and	NULL
IL-10	NULL
.	NULL

This	NULL
response	NULL
is	NULL
important	NULL
for	NULL
humoral	NULL
immunity	NULL
and	NULL
mast	NULL
cell	NULL
development	NULL
seen	NULL
in	NULL
such	NULL
diseases	NULL
as	NULL
hyperimmuno-globulin	NULL
E	NULL
secretion	NULL
syndrome	NULL
.	NULL

It	NULL
has	NULL
been	NULL
appreciated	NULL
that	NULL
cytokines	NULL
secreted	NULL
by	NULL
Th2	NULL
cells	NULL
can	NULL
dramatically	NULL
modulate	NULL
the	NULL
responses	NULL
of	NULL
cells	NULL
involved	NULL
in	NULL
a	NULL
Th1	NULL
immune	NULL
response	NULL
.	NULL

For	NULL
example	NULL
,	NULL
IL-4	NULL
can	NULL
modulate	NULL
the	NULL
expression	NULL
of	NULL
early	NULL
response	NULL
genes	NULL
induced	NULL
by	NULL
IFN	NULL
and	NULL
IFNy	NULL
.	NULL
``	NULL

Likewise	NULL
,	NULL
IFNy	NULL
can	NULL
affect	NULL
the	NULL
response	NULL
of	NULL
cells	NULL
to	NULL
IL-4	NULL
.	NULL

Whereas	NULL
it	NULL
is	NULL
known	NULL
that	NULL
IL-10	NULL
can	NULL
effectively	NULL
block	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
activation	NULL
of	NULL
monocytes	NULL
,	NULL
'	NULL
``	NULL
its	NULL
effects	NULL
on	NULL
direct	NULL
IFN	NULL
activation	NULL
of	NULL
genes	NULL
are	NULL
poorly	NULL
understood	NULL
.	NULL

IFNs	NULL
and	NULL
IL-10	NULL
bind	NULL
to	NULL
their	NULL
cognate	NULL
receptors	NULL
and	NULL
initiate	NULL
a	NULL
signal	NULL
that	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
Janus	NULL
kinase	NULL
(	NULL
Jak	NULL
)	NULL
and	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
proteins	NULL
,	NULL
leading	NULL
to	NULL
transcription	NULL
of	NULL
early	NULL
response	NULL
genes	NULL
.	NULL

!	NULL

IL-10	NULL
activates	NULL
Tyk2	NULL
,	NULL
Jak1	NULL
,	NULL
STAT1	NULL
,	NULL
and	NULL
STAT3	NULL
.	NULL
``	NULL

''	NULL
IFN	NULL
activates	NULL
Tyk2	NULL
,	NULL
Jak1	NULL
,	NULL
STAT1	NULL
,	NULL
STAT2	NULL
,	NULL
STAT3	NULL
,	NULL
and	NULL
STATS	NULL
.	NULL

IFNy	NULL
activates	NULL
Jakl1	NULL
,	NULL
Jak2	NULL
,	NULL
STAT1	NULL
,	NULL
and	NULL
,	NULL
in	NULL
some	NULL
cell	NULL
lines	NULL
,	NULL
Although	NULL
there	NULL
is	NULL
some	NULL
overlap	NULL
among	NULL
the	NULL
proteins	NULL
activated	NULL
by	NULL
these	NULL
three	NULL
cytokines	NULL
,	NULL
there	NULL
is	NULL
no	NULL
clear	NULL
explanation	NULL
from	NULL
this	NULL
information	NULL
as	NULL
to	NULL
why	NULL
one	NULL
IFN	NULL
or	NULL
one	NULL
IL	NULL
should	NULL
inhibit	NULL
the	NULL
action	NULL
of	NULL
others	NULL
.	NULL

We	NULL
hypothesized	NULL
several	NULL
years	NULL
ago	NULL
that	NULL
GM-CSF	NULL
could	NULL
inhibit	NULL
the	NULL
expression	NULL
of	NULL
IFNy-induced	NULL
genes	NULL
by	NULL
activating	NULL
a	NULL
new	NULL
STAT	NULL
protein	NULL
that	NULL
bound	NULL
to	NULL
the	NULL
same	NULL
y	NULL
activation	NULL
sequence	NULL
(	NULL
GAS	NULL
)	NULL
element	NULL
as	NULL
IFNy-induced	NULL
STAT1	NULL
and	NULL
thus	NULL
prevent	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
FeyRI	NULL
gene	NULL
.	NULL
``	NULL

This	NULL
protein	NULL
was	NULL
subsequently	NULL
determined	NULL
to	NULL
be	NULL
STAT5	NULL
.	NULL

Although	NULL
it	NULL
is	NULL
well	NULL
established	NULL
that	NULL
IL-10	NULL
can	NULL
suppress	NULL
LPS-induced	NULL
responses	NULL
,	NULL
which	NULL
are	NULL
by	NULL
and	NULL
large	NULL
driven	NULL
by	NULL
NFB	NULL
,	NULL
its	NULL
direct	NULL
effect	NULL
on	NULL
the	NULL
ability	NULL
of	NULL
IFNa	NULL
«	NULL
and	NULL
IFNy	NULL
to	NULL
activate	NULL
cells	NULL
by	NULL
an	NULL
NFB-independent	NULL
mechanism	NULL
is	NULL
virtually	NULL
unexplored	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
describe	NULL
the	NULL
ability	NULL
of	NULL
IL-10	NULL
to	NULL
Blood	NULL
,	NULL
Vol	NULL
93	NULL
,	NULL
No	NULL
5	NULL
(	NULL
March	NULL
1	NULL
)	NULL
,	NULL
1999	NULL
;	NULL
pp	NULL
1456-1463	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-10	NULL
INHIBITS	NULL
IFN	NULL
SIGNALING	NULL
inhibit	NULL
the	NULL
expression	NULL
of	NULL
specific	NULL
sets	NULL
of	NULL
IFN	NULL
response	NULL
genes	NULL
.	NULL

We	NULL
show	NULL
that	NULL
IL-10	NULL
can	NULL
suppress	NULL
IFN-induced	NULL
expression	NULL
of	NULL
several	NULL
genes	NULL
by	NULL
inhibiting	NULL
STAT	NULL
1	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
gone	NULL
on	NULL
to	NULL
show	NULL
that	NULL
IL-10	NULL
markedly	NULL
upregulates	NULL
expression	NULL
of	NULL
the	NULL
SOCS3	NULL
gene	NULL
,	NULL
which	NULL
is	NULL
known	NULL
to	NULL
suppress	NULL
cytokine	NULL
activation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Monocytes	NULL
.	NULL

-	NULL
Human	NULL
peripheral	NULL
blood	NULL
leukocytes	NULL
from	NULL
healthy	NULL
donors	NULL
were	NULL
separated	NULL
into	NULL
a	NULL
mononuclear	NULL
cell	NULL
fraction	NULL
and	NULL
then	NULL
were	NULL
subjected	NULL
to	NULL
countercurrent	NULL
centrifugal	NULL
elutriation	NULL
.	NULL

The	NULL
fractions	NULL
enriched	NULL
for	NULL
monocytes	NULL
were	NULL
cultured	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
medium	NULL
(	NULL
DMEM	NULL
;	NULL
GIBCO	NULL
,	NULL
Grand	NULL
Island	NULL
,	NULL
NY	NULL
)	NULL
without	NULL
serum	NULL
for	NULL
45	NULL
to	NULL
60	NULL
minutes	NULL
in	NULL
4-well	NULL
tissue	NULL
culture	NULL
plates	NULL
until	NULL
adherent	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
DMEM	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
Hyclone	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
and	NULL
gentamicin	NULL
(	NULL
50	NULL
ug/mL	NULL
)	NULL
.	NULL

Cells	NULL
prepared	NULL
in	NULL
this	NULL
manner	NULL
are	NULL
greater	NULL
than	NULL
95	NULL
%	NULL
monocytes	NULL
by	NULL
morphology	NULL
and	NULL
staining	NULL
for	NULL
anti-CD14	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
recombinant	NULL
human	NULL
IL-10	NULL
(	NULL
rhuIL-10	NULL
;	NULL
Schering-Plough	NULL
,	NULL
Madison	NULL
,	NULL
NJ	NULL
)	NULL
for	NULL
60	NULL
to	NULL
90	NULL
minutes	NULL
before	NULL
the	NULL
incubation	NULL
with	NULL
IFNa	NULL
(	NULL
Roferon	NULL
;	NULL
Roche	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
or	NULL
IFNy	NULL
(	NULL
Genentech	NULL
,	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
the	NULL
specified	NULL
times	NULL
.	NULL

RNAse	NULL
protection	NULL
assay	NULL
.	NULL

-	NULL
Steady-state	NULL
levels	NULL
of	NULL
mRNA	NULL
induced	NULL
by	NULL
either	NULL
IFNa	NULL
«	NULL
or	NULL
IFNy	NULL
were	NULL
measured	NULL
by	NULL
RNAse	NULL
protection	NULL
assay	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

'*	NULL
For	NULL
the	NULL
assay	NULL
,	NULL
probes	NULL
were	NULL
constructed	NULL
such	NULL
that	NULL
each	NULL
lane	NULL
of	NULL
the	NULL
gel	NULL
contained	NULL
several	NULL
protected	NULL
fragments	NULL
.	NULL

y-Inducible	NULL
gene-10	NULL
(	NULL
IP-10	NULL
)	NULL
,	NULL
a	NULL
chemokine	NULL
with	NULL
anti-angiogenesis	NULL
properties	NULL
,	NULL
was	NULL
linearized	NULL
with	NULL
Pvz	NULL
II	NULL
,	NULL
which	NULL
yielded	NULL
a	NULL
protected	NULL
fragment	NULL
of	NULL
360	NULL
bp	NULL
.	NULL
``	NULL

ISG54	NULL
,	NULL
a	NULL
gene	NULL
induced	NULL
by	NULL
IFNa	NULL
(	NULL
and	NULL
in	NULL
monocytes	NULL
by	NULL
IFNy	NULL
)	NULL
,	NULL
was	NULL
linearized	NULL
with	NULL
Pvu	NULL
II	NULL
,	NULL
and	NULL
this	NULL
yielded	NULL
a	NULL
protected	NULL
fragment	NULL
of	NULL
367	NULL
bp	NULL
.	NULL
``	NULL

Guanylate	NULL
binding	NULL
protein	NULL
(	NULL
GBP	NULL
;	NULL
an	NULL
IFN-	NULL
and	NULL
IFNy-induced	NULL
gene	NULL
)	NULL
was	NULL
linearized	NULL
by	NULL
Asp718.2	NULL
'	NULL
For	NULL
an	NULL
internal	NULL
control	NULL
for	NULL
the	NULL
amount	NULL
of	NULL
RNA	NULL
loaded	NULL
onto	NULL
the	NULL
gel	NULL
,	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
;	NULL
linearized	NULL
with	NULL
Sau3a	NULL
)	NULL
was	NULL
used	NULL
and	NULL
had	NULL
a	NULL
protected	NULL
fragment	NULL
of	NULL
300	NULL
bp	NULL
.	NULL
``	NULL

All	NULL
hybridizations	NULL
were	NULL
performed	NULL
overnight	NULL
at	NULL
56°C	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
subjected	NULL
to	NULL
digestion	NULL
with	NULL
RNAse	NULL
T1	NULL
,	NULL
followed	NULL
by	NULL
separation	NULL
on	NULL
a	NULL
6	NULL
%	NULL
polyacrylamide/urea	NULL
sequencing	NULL
gel	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
phosphorimager	NULL
analysis	NULL
and	NULL
autoradiography	NULL
.	NULL

Northern	NULL
analysis	NULL
.	NULL

-	NULL
Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
cultured	NULL
monocytes	NULL
by	NULL
the	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
method	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

''	NULL
RNA	NULL
precipitates	NULL
were	NULL
pelleted	NULL
by	NULL
microcentrifugation	NULL
and	NULL
redissolved	NULL
in	NULL
100	NULL
uL	NULL
of	NULL
diethylpyrocarbon-ate	NULL
(	NULL
DEPC	NULL
)	NULL
-treated	NULL
sterile	NULL
water	NULL
.	NULL

Equivalent	NULL
amounts	NULL
of	NULL
RNA	NULL
(	NULL
10	NULL
ug/lane	NULL
)	NULL
were	NULL
size-fractionated	NULL
by	NULL
electrophoresis	NULL
in	NULL
1	NULL
%	NULL
agarose	NULL
gels	NULL
containing	NULL
0.66	NULL
mol/L	NULL
formaldehyde	NULL
.	NULL

The	NULL
RNA	NULL
was	NULL
then	NULL
blotted	NULL
by	NULL
overnight	NULL
capillary	NULL
transfer	NULL
onto	NULL
Nytran	NULL
membranes	NULL
(	NULL
Schleicher	NULL
&	NULL
Schuell	NULL
,	NULL
Keene	NULL
,	NULL
NH	NULL
)	NULL
and	NULL
cross-linked	NULL
by	NULL
exposure	NULL
to	NULL
UV	NULL
light	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
then	NULL
prehybridized	NULL
,	NULL
hybridized	NULL
,	NULL
and	NULL
washed	NULL
according	NULL
to	NULL
standard	NULL
procedures	NULL
.	NULL

The	NULL
SOCS3	NULL
probe	NULL
was	NULL
a	NULL
681-bp	NULL
Miu	NULL
I	NULL
fragment	NULL
of	NULL
the	NULL
full-length	NULL
murine	NULL
SOCS3	NULL
cDNA	NULL
,	NULL
**	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
Douglas	NULL
Hilton	NULL
(	NULL
Walter	NULL
and	NULL
Eliza	NULL
Hall	NULL
Institute	NULL
,	NULL
Parkville	NULL
,	NULL
Australia	NULL
)	NULL
.	NULL

Gel-purified	NULL
insert	NULL
DNA	NULL
was	NULL
radiolabeled	NULL
by	NULL
the	NULL
random	NULL
primer	NULL
method	NULL
of	NULL
Feinberg	NULL
and	NULL
Vogelstein®	NULL
``	NULL
to	NULL
a	NULL
specific	NULL
activity	NULL
of	NULL
10°	NULL
epm/ug	NULL
or	NULL
greater	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
assays	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

EMSA	NULL
using	NULL
the	NULL
y	NULL
response	NULL
region	NULL
(	NULL
GRR	NULL
)	NULL
of	NULL
the	NULL
FeyRI	NULL
receptor	NULL
were	NULL
performed	NULL
using	NULL
either	NULL
whole-cell	NULL
extracts	NULL
or	NULL
nuclear	NULL
extracts	NULL
,	NULL
as	NULL
described	NULL
previously	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
This	NULL
element	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
GAS	NULL
element	NULL
found	NULL
within	NULL
many	NULL
IFNy-induced	NULL
genes	NULL
.	NULL

This	NULL
probe	NULL
was	NULL
also	NULL
used	NULL
for	NULL
the	NULL
study	NULL
of	NULL
IFNa-induced	NULL
genes	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
IFN-stimulated	NULL
response	NULL
element	NULL
(	NULL
ISRE	NULL
)	NULL
from	NULL
the	NULL
ISG15	NULL
gene	NULL
,	NULL
which	NULL
is	NULL
recognized	NULL
by	NULL
the	NULL
ISGF3	NULL
complex	NULL
and	NULL
is	NULL
specific	NULL
for	NULL
IFN-induced	NULL
genes	NULL
.	NULL

!	NULL

Immunoprecipitations	NULL
.	NULL

After	NULL
treatment	NULL
with	NULL
IL-10	NULL
and/or	NULL
IFNs	NULL
,	NULL
monocytes	NULL
were	NULL
solubilized	NULL
with	NULL
1	NULL
%	NULL
TX100-containing	NULL
buffer	NULL
,	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
minutes	NULL
,	NULL
and	NULL
then	NULL
centrifuged	NULL
for	NULL
13,0008	NULL
for	NULL
12	NULL
1457	NULL
minutes	NULL
to	NULL
generate	NULL
a	NULL
postnuclear	NULL
extract	NULL
as	NULL
described	NULL
.	NULL
``	NULL

The	NULL
postnuclear	NULL
extracts	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
anti-STAT1	NULL
antibodies	NULL
.	NULL

The	NULL
immunoprecipitates	NULL
were	NULL
separated	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
gels	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
polyvinylidene	NULL
difluoride	NULL
membrane	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
antiphos-photyrosine	NULL
.	NULL

Alternately	NULL
,	NULL
some	NULL
extracts	NULL
were	NULL
analyzed	NULL
directly	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
immunoblotting	NULL
with	NULL
antiphosphotyrosine-STAT1	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Immunoblots	NULL
were	NULL
developed	NULL
using	NULL
either	NULL
horseradish	NULL
peroxidase	NULL
or	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
ECL	NULL
)	NULL
or	NULL
nitroblue	NULL
tetrazolium	NULL
chemistry	NULL
,	NULL
respectively	NULL
.	NULL

RESULTS	NULL
We	NULL
initially	NULL
addressed	NULL
the	NULL
question	NULL
of	NULL
which	NULL
early	NULL
response	NULL
genes	NULL
induced	NULL
by	NULL
IFNs	NULL
might	NULL
be	NULL
inhibited	NULL
by	NULL
IL-10	NULL
.	NULL

Studies	NULL
with	NULL
STAT1-deficient	NULL
mice	NULL
showed	NULL
that	NULL
induction	NULL
of	NULL
IP-10	NULL
is	NULL
dependent	NULL
on	NULL
STAT1	NULL
activation	NULL
.	NULL
``	NULL

''	NULL
The	NULL
IP-10	NULL
gene	NULL
encodes	NULL
a	NULL
chemokine	NULL
of	NULL
the	NULL
cysteine-x-cysteine	NULL
(	NULL
CXC	NULL
)	NULL
type	NULL
that	NULL
is	NULL
rapidly	NULL
activated	NULL
by	NULL
IFNy	NULL
and	NULL
IFNa	NULL
.	NULL

Recent	NULL
data	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
IP-10	NULL
protein	NULL
has	NULL
strong	NULL
anti-angiogenic	NULL
properties	NULL
and	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
inhibiting	NULL
the	NULL
development	NULL
of	NULL
carcinogenic	NULL
tumors	NULL
in	NULL
several	NULL
mouse	NULL
models	NULL
,	NULL
has	NULL
profound	NULL
effects	NULL
on	NULL
chronic	NULL
inflammatory	NULL
conditions	NULL
.	NULL
``	NULL

''	NULL
We	NULL
initially	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
IL-10	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
IP-10	NULL
in	NULL
monocytes	NULL
exposed	NULL
to	NULL
IFNa	NULL
«	NULL
(	NULL
Fig	NULL
1A	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
rapid	NULL
induction	NULL
of	NULL
IP-10	NULL
expression	NULL
that	NULL
was	NULL
markedly	NULL
inhibited	NULL
by	NULL
IL-10	NULL
at	NULL
all	NULL
concentrations	NULL
of	NULL
IFN	NULL
«	NULL
tested	NULL
.	NULL

For	NULL
some	NULL
individuals	NULL
(	NULL
such	NULL
as	NULL
the	NULL
one	NULL
shown	NULL
)	NULL
,	NULL
nearly	NULL
complete	NULL
inhibition	NULL
could	NULL
be	NULL
observed	NULL
.	NULL

Although	NULL
the	NULL
number	NULL
of	NULL
donors	NULL
were	NULL
only	NULL
two	NULL
per	NULL
group	NULL
,	NULL
it	NULL
was	NULL
clear	NULL
from	NULL
the	NULL
autoradiograph	NULL
that	NULL
at	NULL
higher	NULL
concentrations	NULL
of	NULL
IFN	NULL
,	NULL
there	NULL
was	NULL
less	NULL
inhibition	NULL
by	NULL
IL-10	NULL
.	NULL

IFNy-stimulated	NULL
IP-10	NULL
RNA	NULL
expression	NULL
was	NULL
inhibited	NULL
by	NULL
pretreatment	NULL
of	NULL
monocytes	NULL
with	NULL
IL-10	NULL
(	NULL
Fig	NULL
1B	NULL
)	NULL
.	NULL

At	NULL
virtually	NULL
all	NULL
doses	NULL
of	NULL
IFNy	NULL
,	NULL
over	NULL
a	NULL
range	NULL
that	NULL
occupies	NULL
approximately	NULL
10	NULL
%	NULL
to	NULL
100	NULL
%	NULL
of	NULL
the	NULL
receptors	NULL
for	NULL
IFNy	NULL
,	NULL
IL-10	NULL
suppressed	NULL
IFNy-induced	NULL
IP-10	NULL
RNA	NULL
expression	NULL
by	NULL
59	NULL
%	NULL
to	NULL
68	NULL
%	NULL
.	NULL

However	NULL
,	NULL
at	NULL
the	NULL
lower	NULL
concentrations	NULL
of	NULL
IFNy	NULL
,	NULL
inhibition	NULL
tended	NULL
to	NULL
be	NULL
greater	NULL
.	NULL

We	NULL
went	NULL
on	NULL
to	NULL
confirm	NULL
that	NULL
there	NULL
was	NULL
no	NULL
change	NULL
in	NULL
receptor	NULL
number	NULL
of	NULL
affinity	NULL
by	NULL
directly	NULL
measuring	NULL
the	NULL
number	NULL
of	NULL
IFNy	NULL
receptors	NULL
on	NULL
monocytes	NULL
after	NULL
IL-10	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
IP-10	NULL
,	NULL
we	NULL
also	NULL
examined	NULL
IFN	NULL
activation	NULL
of	NULL
ISG54	NULL
(	NULL
Fig	NULL
1C	NULL
)	NULL
.	NULL

Although	NULL
ISG54	NULL
was	NULL
one	NULL
of	NULL
the	NULL
first	NULL
genes	NULL
recognized	NULL
as	NULL
an	NULL
IFN-inducible	NULL
early	NULL
response	NULL
gene	NULL
,	NULL
virtually	NULL
no	NULL
information	NULL
is	NULL
available	NULL
regarding	NULL
the	NULL
function	NULL
of	NULL
the	NULL
protein	NULL
that	NULL
it	NULL
encodes	NULL
.	NULL

IFNa-stimulated	NULL
ISG54	NULL
is	NULL
entirely	NULL
dependent	NULL
on	NULL
the	NULL
assembly	NULL
of	NULL
a	NULL
complex	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
STAT1	NULL
,	NULL
STAT2	NULL
,	NULL
and	NULL
p48	NULL
,	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
ISRE	NULL
enhancer	NULL
.	NULL

Prior	NULL
incubation	NULL
of	NULL
monocytes	NULL
with	NULL
IL-10	NULL
resulted	NULL
in	NULL
IFNa-induced	NULL
inhibition	NULL
of	NULL
the	NULL
accumulation	NULL
of	NULL
ISG54	NULL
RNA	NULL
,	NULL
compared	NULL
with	NULL
incubation	NULL
with	NULL
IFNa	NULL
alone	NULL
(	NULL
Fig	NULL
1C	NULL
)	NULL
.	NULL

The	NULL
observed	NULL
inhibition	NULL
by	NULL
IL-10	NULL
was	NULL
greater	NULL
when	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
submaxi-mal	NULL
concentrations	NULL
of	NULL
IFNa	NULL
«	NULL
(	NULL
49	NULL
%	NULL
v	NULL
17	NULL
%	NULL
)	NULL
.	NULL

There	NULL
is	NULL
some	NULL
variability	NULL
,	NULL
and	NULL
some	NULL
donors	NULL
clearly	NULL
show	NULL
inhibition	NULL
of	NULL
greater	NULL
than	NULL
60	NULL
%	NULL
.	NULL

Early	NULL
reports	NULL
discounted	NULL
the	NULL
ability	NULL
of	NULL
IFNy	NULL
to	NULL
induce	NULL
the	NULL
ISG54	NULL
gene	NULL
because	NULL
of	NULL
the	NULL
lack	NULL
of	NULL
a	NULL
GRR	NULL
sequence	NULL
within	NULL
its	NULL
5	NULL
regulatory	NULL
region	NULL
.	NULL

However	NULL
,	NULL
IFNy	NULL
treatment	NULL
of	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
can	NULL
clearly	NULL
stimulate	NULL
the	NULL
accumulation	NULL
of	NULL
ISG54	NULL
RNA	NULL
(	NULL
Fig	NULL
1D	NULL
)	NULL
.	NULL

Incubation	NULL
of	NULL
monocytes	NULL
with	NULL
IL-10	NULL
showed	NULL
a	NULL
consistent	NULL
suppressive	NULL
effect	NULL
on	NULL
IFNy-stimulated	NULL
ISG54	NULL
RNA	NULL
expression	NULL
to	NULL
a	NULL
similar	NULL
extent	NULL
as	NULL
that	NULL
observed	NULL
for	NULL
the	NULL
IP-10	NULL
gene	NULL
.	NULL

In	NULL
many	NULL
donors	NULL
,	NULL
the	NULL
suppression	NULL
reached	NULL
levels	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1458	NULL
ITO	NULL
ET	NULL
AL	NULL
$	NULL
S	NULL
a	NULL
$	NULL
a	NULL
8	NULL
_	NULL
®	NULL
x€	NULL
€	NULL
0	NULL
®	NULL
C	NULL
)	NULL
®	NULL
$	NULL
ag	NULL
p	NULL
$	NULL
__	NULL
&	NULL
&	NULL
\	NULL
0	NULL
(	NULL
5.x	NULL
®°	NULL
¢	NULL
\	NULL
090	NULL
<	NULL
5	NULL
“	NULL
c	NULL
S	NULL
8	NULL
<	NULL
3	NULL
Cy	NULL
$	NULL
6	NULL
A	NULL
(	NULL
$	NULL
0	NULL
0x	NULL
\Q\	NULL
Ox	NULL
\Q\\	NULL
66	NULL
0x	NULL
\Q\\	NULL
o66	NULL
Qé	NULL
‘	NULL
»	NULL
\Q\	NULL
Qé¢	NULL
5®	NULL
066	NULL
Qé	NULL
‘	NULL
»	NULL
NQ	NULL
C	NULL
C	NULL
V	NULL
Co	NULL
v_	NULL
4	NULL
£	NULL
v	NULL
C	NULL
_C	NULL
v_	NULL
<	NULL
&	NULL
C	NULL
<	NULL
y	NULL
ts	NULL
e	NULL
-	NULL
==	NULL
isas4	NULL
-	NULL
C	NULL
%	NULL
©	NULL
IP10	NULL
--	NULL
»	NULL
a	NULL
»	NULL
«	NULL
k	NULL
«	NULL
Ue	NULL
-	NULL
{	NULL
coron-	NULL
»	NULL
UUP	NULL
OD	NULL
OP	NULL
O	NULL
@	NULL
m	NULL
as	NULL
as	NULL
GAPDH	NULL
-	NULL
»	NULL
Wit	NULL
«	NULL
aw	NULL
4	NULL
*	NULL
r	NULL
t	NULL
UW	NULL
an	NULL
a	NULL
as	NULL
an	NULL
(	NULL
6	NULL
-	NULL
w	NULL
«	NULL
s	NULL
te	NULL
-	NULL
%	NULL
%	NULL
Inhibition	NULL
49	NULL
+	NULL
36	NULL
-	NULL
30	NULL
+14	NULL
[	NULL
L7—	NULL
a	NULL
%	NULL
Inhibition	NULL
852	NULL
762	NULL
802	NULL
1§G	NULL
@	NULL
54	NULL
n=	NULL
3	NULL
n=	NULL
3	NULL
=	NULL
IP10	NULL
n=	NULL
n=	NULL
n=	NULL
a	NULL
a	NULL
a	NULL
6	NULL
&	NULL
©	NULL
8	NULL
&	NULL
©	NULL
&	NULL
£	NULL
8	NULL
8	NULL
a	NULL
S	NULL
A	NULL
&	NULL
C	NULL
gl	NULL
P	NULL
ey	NULL
3	NULL
c	NULL
o	NULL
Re	NULL
R	NULL
C	NULL
Ce	NULL
0	NULL
SC	NULL
4,09	NULL
CO	NULL
s	NULL
o	NULL
aA	NULL
``	NULL
C	NULL
8	NULL
¢	NULL
``	NULL
©	NULL
®	NULL
<	NULL
poo	NULL
``	NULL
C	NULL
C	NULL
_	NULL
<	NULL
©	NULL
uS	NULL
ad	NULL
80	NULL
uC	NULL
U8	NULL
WS	NULL
ad	NULL
C	NULL
[	NULL
S	NULL
,	NULL
[	NULL
C	NULL
$	NULL
[	NULL
,	NULL
S	NULL
,	NULL
F	NULL
8	NULL
SC	NULL
S0	NULL
``	NULL
s	NULL
®	NULL
C	NULL
SV	NULL
)	NULL
CV	NULL
$	NULL
&	NULL
p	NULL
@	NULL
&	NULL
y	NULL
€	NULL
y	NULL
€	NULL
)	NULL
w	NULL
B	NULL
cong	NULL
.	NULL

&	NULL
i	NULL
``	NULL
S	NULL
3	NULL
3	NULL
)	NULL
1SG54	NULL
-	NULL
»	NULL
®	NULL
P10	NULL
|	NULL
-	NULL
»	NULL
C3	NULL
«	NULL
-	NULL
aD	NULL
dh	NULL
Cs	NULL
capPoH	NULL
--	NULL
»	NULL
«	NULL
teo	NULL
un	NULL
ws	NULL
GAPDH	NULL
--	NULL
»	NULL
Milk	NULL
z	NULL
t	NULL
C	NULL
a	NULL
&	NULL
&	NULL
-	NULL
L	NULL
Ce	NULL
C	NULL
3	NULL
Ca	NULL
``	NULL
<	NULL
a	NULL
#	NULL
#	NULL
m	NULL
#	NULL
&	NULL
%	NULL
Inhibition	NULL
68	NULL
+	NULL
23	NULL
67	NULL
59	NULL
+	NULL
36	NULL
%	NULL
Inhibition	NULL
63	NULL
+	NULL
23	NULL
50	NULL
68	NULL
+	NULL
32	NULL
IP10	NULL
n=	NULL
4	NULL
n=	NULL
2	NULL
n=	NULL
6	NULL
1SG54	NULL
n=	NULL
3	NULL
n=	NULL
2	NULL
n=	NULL
6	NULL
Fig	NULL
1	NULL
.	NULL

_	NULL
IL-10	NULL
inhibits	NULL
the	NULL
induction	NULL
of	NULL
IP-10	NULL
and	NULL
ISGS54	NULL
by	NULL
IFNa	NULL
«	NULL
and	NULL
IFNy	NULL
.	NULL

Monocytes	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
ng/	NULL
mL	NULL
of	NULL
IL-10	NULL
for	NULL
60	NULL
minutes	NULL
before	NULL
treatment	NULL
with	NULL
the	NULL
indicated	NULL
doses	NULL
of	NULL
(	NULL
A	NULL
)	NULL
IFN	NULL
«	NULL
or	NULL
(	NULL
B	NULL
)	NULL
IFNy	NULL
for	NULL
90	NULL
minutes	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
from	NULL
the	NULL
cells	NULL
,	NULL
and	NULL
RNAse	NULL
protection	NULL
assays	NULL
were	NULL
performed	NULL
.	NULL

The	NULL
arrows	NULL
indicate	NULL
the	NULL
protected	NULL
fragment	NULL
corresponding	NULL
to	NULL
IP-10	NULL
and	NULL
the	NULL
control	NULL
gene	NULL
,	NULL
GAPDH	NULL
.	NULL

IL-10	NULL
inhibits	NULL
IFN-induced	NULL
expression	NULL
of	NULL
ISG54	NULL
by	NULL
(	NULL
C	NULL
)	NULL
IFN	NULL
«	NULL
or	NULL
(	NULL
D	NULL
)	NULL
IFNy	NULL
.	NULL

The	NULL
arrow	NULL
s	NULL
indicate	NULL
the	NULL
protected	NULL
gene	NULL
fragment	NULL
for	NULL
ISGS54	NULL
and	NULL
the	NULL
control	NULL
gene	NULL
,	NULL
GAPDH	NULL
.	NULL

For	NULL
all	NULL
RNAse	NULL
protection	NULL
assays	NULL
,	NULL
the	NULL
ratio	NULL
of	NULL
the	NULL
values	NULL
for	NULL
the	NULL
IFN-induced	NULL
gene	NULL
divided	NULL
by	NULL
those	NULL
for	NULL
the	NULL
control	NULL
(	NULL
GAPDH	NULL
)	NULL
gene	NULL
was	NULL
computed	NULL
,	NULL
and	NULL
for	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
pretreated	NULL
with	NULL
IL-10	NULL
followed	NULL
by	NULL
IFN	NULL
.	NULL

The	NULL
values	NULL
were	NULL
calculated	NULL
from	NULL
Phospho-Imager	NULL
data	NULL
analysis	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
inhibition	NULL
was	NULL
calculated	NULL
by	NULL
subtracting	NULL
the	NULL
values	NULL
for	NULL
cells	NULL
treated	NULL
with	NULL
IL-10	NULL
from	NULL
values	NULL
for	NULL
IFN-treated	NULL
cells	NULL
and	NULL
dividing	NULL
this	NULL
number	NULL
by	NULL
the	NULL
values	NULL
for	NULL
the	NULL
cells	NULL
treated	NULL
with	NULL
IL-10	NULL
and	NULL
IFN	NULL
.	NULL

The	NULL
values	NULL
under	NULL
the	NULL
gel	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
2	NULL
to	NULL
6	NULL
experiments	NULL
+	NULL
standard	NULL
deviation	NULL
at	NULL
the	NULL
various	NULL
doses	NULL
.	NULL

of	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
at	NULL
lower	NULL
doses	NULL
of	NULL
IFNy	NULL
(	NULL
1	NULL
ng/mL	NULL
,	NULL
in	NULL
this	NULL
experiment	NULL
;	NULL
Fig	NULL
1D	NULL
)	NULL
.	NULL

These	NULL
concentrations	NULL
of	NULL
IFNy	NULL
are	NULL
generally	NULL
at	NULL
a	NULL
level	NULL
in	NULL
which	NULL
receptors	NULL
are	NULL
only	NULL
10	NULL
%	NULL
occupied	NULL
,	NULL
but	NULL
genes	NULL
are	NULL
maximally	NULL
expressed	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
to	NULL
IP-10	NULL
and	NULL
ISG54	NULL
genes	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
ability	NULL
of	NULL
IL-10	NULL
to	NULL
suppress	NULL
the	NULL
induction	NULL
of	NULL
several	NULL
other	NULL
IFN-inducible	NULL
genes	NULL
.	NULL

These	NULL
genes	NULL
included	NULL
ICAM-1	NULL
and	NULL
IRF-1	NULL
.	NULL

Although	NULL
the	NULL
IRF-1	NULL
gene	NULL
has	NULL
GAS	NULL
elements	NULL
that	NULL
drive	NULL
its	NULL
transcription	NULL
by	NULL
IFNy	NULL
,	NULL
there	NULL
was	NULL
no	NULL
perceptible	NULL
inhibition	NULL
by	NULL
IL-10	NULL
in	NULL
monocytes	NULL
.	NULL

For	NULL
ICAM-1	NULL
,	NULL
only	NULL
IFNy	NULL
was	NULL
capable	NULL
of	NULL
inducing	NULL
its	NULL
expression	NULL
;	NULL
IFNa	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

ICAM-1	NULL
expression	NULL
is	NULL
clearly	NULL
important	NULL
for	NULL
immune	NULL
cell	NULL
adherence	NULL
and	NULL
tumor	NULL
cell	NULL
recognition	NULL
.	NULL
``	NULL

''	NULL
For	NULL
those	NULL
experiments	NULL
in	NULL
which	NULL
this	NULL
gene	NULL
had	NULL
increased	NULL
expression	NULL
of	NULL
at	NULL
least	NULL
fourfold	NULL
after	NULL
exposure	NULL
to	NULL
IFNy	NULL
,	NULL
pretreatment	NULL
with	NULL
IL-10	NULL
inhibited	NULL
ICAM-1	NULL
RNA	NULL
expression	NULL
by	NULL
50	NULL
%	NULL
(	NULL
over	NULL
a	NULL
range	NULL
of	NULL
IFNy	NULL
concentrations	NULL
of	NULL
0.25	NULL
to	NULL
10	NULL
ng/mL	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
recent	NULL
report	NULL
describing	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
IL-10	NULL
on	NULL
IFNy-induced	NULL
ICAM-1	NULL
expression	NULL
in	NULL
monocytes	NULL
.	NULL
``	NULL

Both	NULL
IFN	NULL
«	NULL
and	NULL
IFNy	NULL
activate	NULL
STAT	NULL
's	NULL
,	NULL
which	NULL
activate	NULL
gene	NULL
expression	NULL
by	NULL
binding	NULL
to	NULL
ISRE	NULL
and	NULL
GAS	NULL
elements	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
IFN-inducible	NULL
genes	NULL
.	NULL

IFNy	NULL
essentially	NULL
activates	NULL
only	NULL
STAT1	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
,	NULL
although	NULL
one	NULL
group	NULL
has	NULL
reported	NULL
the	NULL
activation	NULL
of	NULL
STATS	NULL
in	NULL
the	NULL
histio-cytic	NULL
lymphoma	NULL
cell	NULL
line	NULL
,	NULL
U937	NULL
.	NULL

``	NULL
°	NULL
IFNa	NULL
can	NULL
activate	NULL
several	NULL
STAT	NULL
's	NULL
,	NULL
including	NULL
STAT1	NULL
,	NULL
STAT2	NULL
,	NULL
STAT3	NULL
,	NULL
STAT4	NULL
,	NULL
and	NULL
STATS	NULL
.	NULL

Multimers	NULL
of	NULL
these	NULL
STAT	NULL
's	NULL
bind	NULL
to	NULL
ISRE	NULL
or	NULL
GAS	NULL
enhancers	NULL
to	NULL
facilitate	NULL
gene	NULL
transcription	NULL
.	NULL

When	NULL
we	NULL
investigated	NULL
the	NULL
effect	NULL
of	NULL
IL-10	NULL
on	NULL
the	NULL
IFNa-induced	NULL
formation	NULL
of	NULL
ISGF3	NULL
(	NULL
Fig	NULL
2A	NULL
)	NULL
,	NULL
we	NULL
noted	NULL
that	NULL
there	NULL
was	NULL
a	NULL
clear	NULL
dose	NULL
response	NULL
with	NULL
respect	NULL
to	NULL
IFNa	NULL
concentrations	NULL
,	NULL
such	NULL
that	NULL
at	NULL
100	NULL
U/mL	NULL
(	NULL
0.5	NULL
ng/mL	NULL
)	NULL
of	NULL
IFN	NULL
,	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-10	NULL
INHIBITS	NULL
IFN	NULL
SIGNALING	NULL
a	NULL
0\	NULL
@	NULL
A	NULL
®	NULL
&	NULL
C	NULL
a	NULL
&	NULL
o66	NULL
x	NULL
<	NULL
x	NULL
&	NULL
w	NULL
<	NULL
w	NULL
.	NULL

<	NULL
--	NULL
ISGF3	NULL
1	NULL
2	NULL
3	NULL
4	NULL
B	NULL
100	NULL
[	NULL
g	NULL
-	NULL
80f	NULL
5	NULL
C	NULL
E	NULL
I	NULL
6	NULL
60	NULL
.	NULL

4	NULL
CD	NULL
LL	NULL
G	NULL
®	NULL
<	NULL
40	NULL
.	NULL

4	NULL
C	NULL
.6	NULL
s	NULL
8	NULL
€	NULL
-	NULL
20	NULL
}	NULL
{	NULL
ze	NULL
0	NULL
100	NULL
200	NULL
1000	NULL
{	NULL
n=	NULL
3	NULL
)	NULL
(	NULL
n=	NULL
4	NULL
)	NULL
(	NULL
n=	NULL
4	NULL
)	NULL
Concentration	NULL
of	NULL
IFN	NULL
«	NULL
(	NULL
U/ml	NULL
)	NULL
<	NULL
--	NULL
FcRFa	NULL
1	NULL
2	NULL
3	NULL
~	NULL
4	NULL
Fig	NULL
2	NULL
.	NULL

EMSA	NULL
analysis	NULL
of	NULL
IFN	NULL
«	NULL
-induced	NULL
DNA	NULL
binding	NULL
complexes	NULL
.	NULL

Monocytes	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
ng/mL	NULL
of	NULL
IL-10	NULL
for	NULL
90	NULL
minutes	NULL
,	NULL
followed	NULL
by	NULL
treatment	NULL
with	NULL
the	NULL
indicated	NULL
doses	NULL
of	NULL
IFNa	NULL
for	NULL
30	NULL
minutes	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
EMSA	NULL
were	NULL
performed	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
using	NULL
the	NULL
ISRE	NULL
probe	NULL
,	NULL
which	NULL
represents	NULL
binding	NULL
of	NULL
the	NULL
ISGF3	NULL
complex	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Summaries	NULL
of	NULL
the	NULL
Phospho-Imager	NULL
data	NULL
from	NULL
several	NULL
experiments	NULL
,	NULL
such	NULL
as	NULL
those	NULL
presented	NULL
in	NULL
(	NULL
A	NULL
)	NULL
,	NULL
were	NULL
quanti-tated	NULL
using	NULL
the	NULL
Phospho-Imager	NULL
.	NULL

The	NULL
value	NULL
given	NULL
is	NULL
the	NULL
mean	NULL
+	NULL
standard	NULL
deviation	NULL
.	NULL

(	NULL
C	NULL
)	NULL
EMSA	NULL
using	NULL
the	NULL
GRR	NULL
probe	NULL
,	NULL
which	NULL
predominantly	NULL
measures	NULL
binding	NULL
of	NULL
STATA	NULL
dimers	NULL
.	NULL

inhibition	NULL
by	NULL
IL-10	NULL
was	NULL
greater	NULL
than	NULL
90	NULL
%	NULL
,	NULL
yet	NULL
at	NULL
1,000	NULL
U/mL	NULL
of	NULL
IFNa	NULL
,	NULL
inhibition	NULL
by	NULL
IL-10	NULL
had	NULL
decreased	NULL
to	NULL
approximately	NULL
35	NULL
%	NULL
(	NULL
Fig	NULL
2B	NULL
)	NULL
.	NULL

This	NULL
result	NULL
suggested	NULL
that	NULL
formation	NULL
of	NULL
ISGF3	NULL
was	NULL
markedly	NULL
inhibited	NULL
by	NULL
IL-10	NULL
at	NULL
lower	NULL
doses	NULL
of	NULL
IFNa	NULL
.	NULL

However	NULL
,	NULL
higher	NULL
doses	NULL
of	NULL
IFNa	NULL
could	NULL
overcome	NULL
to	NULL
some	NULL
extent	NULL
this	NULL
inhibition	NULL
by	NULL
increased	NULL
receptor	NULL
occupancy	NULL
,	NULL
suggesting	NULL
that	NULL
there	NULL
may	NULL
be	NULL
a	NULL
limiting	NULL
amount	NULL
of	NULL
an	NULL
inhibitory	NULL
component	NULL
induced	NULL
by	NULL
IL-10	NULL
whose	NULL
function	NULL
can	NULL
be	NULL
competed	NULL
for	NULL
when	NULL
more	NULL
IFNa	NULL
binds	NULL
to	NULL
the	NULL
cell	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
exogenous	NULL
p48	NULL
to	NULL
the	NULL
reactions	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
complex	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
ISRE	NULL
probe	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

When	NULL
a	NULL
similar	NULL
experiment	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
GRR	NULL
probe	NULL
,	NULL
which	NULL
is	NULL
recognized	NULL
by	NULL
STAT1	NULL
dimers	NULL
,	NULL
the	NULL
same	NULL
result	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
2C	NULL
)	NULL
.	NULL

Because	NULL
1459	NULL
binding	NULL
to	NULL
the	NULL
GRR	NULL
probe	NULL
probably	NULL
occurs	NULL
through	NULL
a	NULL
mechanism	NULL
different	NULL
from	NULL
that	NULL
to	NULL
the	NULL
ISRE	NULL
(	NULL
ie	NULL
,	NULL
neither	NULL
p48	NULL
nor	NULL
STAT2	NULL
is	NULL
involved	NULL
)	NULL
,	NULL
this	NULL
result	NULL
implies	NULL
that	NULL
STAT1	NULL
may	NULL
potentially	NULL
be	NULL
a	NULL
target	NULL
of	NULL
IL-10	NULL
suppression	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
IL-10	NULL
on	NULL
IFN	NULL
«	NULL
activation	NULL
of	NULL
STAT1	NULL
directly	NULL
through	NULL
the	NULL
use	NULL
of	NULL
an	NULL
antibody	NULL
that	NULL
recognizes	NULL
only	NULL
the	NULL
tyrosine-phosphorylated	NULL
form	NULL
of	NULL
STAT1	NULL
(	NULL
Fig	NULL
3A	NULL
)	NULL
.	NULL

IL-10	NULL
pretreatment	NULL
of	NULL
monocytes	NULL
resulted	NULL
in	NULL
reduced	NULL
levels	NULL
of	NULL
tyrosine-phosphorylated	NULL
STAT1	NULL
when	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
lower	NULL
doses	NULL
of	NULL
IFNa	NULL
(	NULL
200	NULL
U/mL	NULL
or	NULL
lower	NULL
)	NULL
.	NULL

This	NULL
result	NULL
correlated	NULL
with	NULL
IL-10-mediated	NULL
inhibition	NULL
of	NULL
IFN-induced	NULL
gene	NULL
expression	NULL
and	NULL
formation	NULL
of	NULL
ISGF3	NULL
.	NULL

All	NULL
lanes	NULL
expressed	NULL
equal	NULL
amounts	NULL
of	NULL
STAT1	NULL
loaded	NULL
onto	NULL
the	NULL
gel	NULL
(	NULL
Fig	NULL
3B	NULL
)	NULL
.	NULL

With	NULL
increasing	NULL
doses	NULL
of	NULL
IFN	NULL
«	NULL
,	NULL
there	NULL
was	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
inhibitory	NULL
action	NULL
y	NULL
-	NULL
C	NULL
8	NULL
x	NULL
«	NULL
Ss	NULL
Cy	NULL
Oy	NULL
Cy	NULL
A	NULL
IP	NULL
:	NULL
anti-STAT-1	NULL
Blot	NULL
:	NULL
anti-P-STAT-1	NULL
«	NULL
«	NULL
»	NULL
-	NULL
agp	NULL
ame	NULL
~P-STAT-1	NULL
B	NULL
_	NULL
IP	NULL
:	NULL
anti-STAT	NULL
Blot	NULL
:	NULL
anti-STAT-1	NULL
«	NULL
o	NULL
«	NULL
n	NULL
«	NULL
s	NULL
on	NULL
am	NULL
am	NULL
-S|/|-1	NULL
C	NULL
100	NULL
__	NULL
--	NULL
so	NULL
L	NULL
T	NULL
E	NULL
eo	NULL
|-	NULL
has	NULL
se	NULL
&	NULL
8	NULL
=	NULL
40	NULL
.	NULL

E=	NULL
<	NULL
-	NULL
<	NULL
3°	NULL
20	NULL
-	NULL
o	NULL
100	NULL
200	NULL
1000	NULL
(	NULL
n	NULL
=	NULL
2	NULL
)	NULL
{	NULL
n	NULL
=	NULL
3	NULL
)	NULL
(	NULL
n=	NULL
6	NULL
)	NULL
Concentration	NULL
of	NULL
IFN	NULL
«	NULL
(	NULL
U/m	NULL
!	NULL

1	NULL
)	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
(	NULL
A	NULL
)	NULL
IL-10	NULL
inhibits	NULL
the	NULL
IFN	NULL
«	NULL
-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
.	NULL

Monocytes	NULL
were	NULL
treated	NULL
with	NULL
10	NULL
ng/mL	NULL
of	NULL
IL-10	NULL
for	NULL
60	NULL
minutes	NULL
,	NULL
followed	NULL
by	NULL
treatment	NULL
for	NULL
30	NULL
minutes	NULL
with	NULL
the	NULL
indicated	NULL
doses	NULL
of	NULL
IFN	NULL
«	NULL
at	NULL
200	NULL
U/mL	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
or	NULL
1,000	NULL
U/mL	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
were	NULL
applied	NULL
to	NULL
an	NULL
SDS-PAGE	NULL
gel	NULL
.	NULL

Separated	NULL
proteins	NULL
were	NULL
transferred	NULL
and	NULL
a	NULL
Western	NULL
blot	NULL
was	NULL
performed	NULL
with	NULL
an	NULL
antibody	NULL
that	NULL
recognizes	NULL
tyrosine-phosphorylated	NULL
STATA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
reprobed	NULL
for	NULL
STATA	NULL
.	NULL

(	NULL
C	NULL
)	NULL
The	NULL
inhibitory	NULL
effects	NULL
of	NULL
IL-10	NULL
on	NULL
IFNa-stimulated	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
are	NULL
dose-dependent	NULL
.	NULL

Monocytes	NULL
were	NULL
prepared	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
autoradiographs	NULL
were	NULL
scanned	NULL
for	NULL
phosphorylated	NULL
STAT1	NULL
using	NULL
a	NULL
Laser	NULL
densitometer	NULL
(	NULL
LKB-Brommo	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

The	NULL
numbers	NULL
in	NULL
parentheses	NULL
refer	NULL
to	NULL
the	NULL
number	NULL
of	NULL
experiments	NULL
performed	NULL
with	NULL
different	NULL
donors	NULL
.	NULL

The	NULL
data	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
standard	NULL
deviation	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1460	NULL
of	NULL
IL-10	NULL
on	NULL
STAT1	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
3A	NULL
,	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
,	NULL
such	NULL
that	NULL
at	NULL
1,000	NULL
U/mL	NULL
(	NULL
5	NULL
ng/mL	NULL
)	NULL
,	NULL
inhibition	NULL
was	NULL
still	NULL
present	NULL
,	NULL
but	NULL
reduced	NULL
to	NULL
approximately	NULL
40	NULL
%	NULL
(	NULL
Fig	NULL
3C	NULL
)	NULL
.	NULL

This	NULL
was	NULL
consistent	NULL
with	NULL
the	NULL
results	NULL
observed	NULL
for	NULL
gene	NULL
induction	NULL
and	NULL
ISRE	NULL
binding	NULL
.	NULL

Pretreatment	NULL
of	NULL
cells	NULL
with	NULL
IL-10	NULL
also	NULL
suppressed	NULL
the	NULL
ability	NULL
of	NULL
IFNy-stimulated	NULL
STAT1	NULL
dimeric	NULL
complexes	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
GRR	NULL
probe	NULL
(	NULL
Fig	NULL
4A	NULL
,	NULL
lane	NULL
3	NULL
v	NULL
4	NULL
)	NULL
.	NULL

There	NULL
was	NULL
no	NULL
evidence	NULL
of	NULL
IL-10-stimulated	NULL
STAT	NULL
binding	NULL
to	NULL
the	NULL
GRR	NULL
probe	NULL
,	NULL
because	NULL
the	NULL
time	NULL
of	NULL
treatment	NULL
with	NULL
IL-10	NULL
(	NULL
t	NULL
=	NULL
90	NULL
minutes	NULL
)	NULL
before	NULL
IFNy	NULL
was	NULL
sufficient	NULL
for	NULL
this	NULL
binding	NULL
to	NULL
have	NULL
dissipated	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
IL-10	NULL
inhibited	NULL
IFNy	NULL
activation	NULL
of	NULL
GRR-binding	NULL
complexes	NULL
at	NULL
several	NULL
concentrations	NULL
of	NULL
IFNy	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

The	NULL
inability	NULL
to	NULL
repeatedly	NULL
scan	NULL
the	NULL
same	NULL
exact	NULL
region	NULL
in	NULL
EMSA	NULL
autoradiographs	NULL
from	NULL
different	NULL
experiments	NULL
leads	NULL
to	NULL
the	NULL
variation	NULL
observed	NULL
in	NULL
the	NULL
plot	NULL
.	NULL

We	NULL
also	NULL
looked	NULL
directly	NULL
at	NULL
the	NULL
ability	NULL
of	NULL
IL-10	NULL
to	NULL
block	NULL
activation	NULL
of	NULL
STAT1	NULL
using	NULL
phosphotyrosine	NULL
immunoblotting	NULL
.	NULL

Monocytes	NULL
were	NULL
pretreated	NULL
with	NULL
IL-10	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
IFNy	NULL
for	NULL
15	NULL
minutes	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
lysed	NULL
,	NULL
A	NULL
A	NULL
Q\	NULL
@	NULL
tw	NULL
1	NULL
2	NULL
120	NULL
H	NULL
40o	NULL
}	NULL
-o	NULL
&	NULL
$	NULL
®	NULL
-	NULL
sol-	NULL
(	NULL
«	NULL
]	NULL
tr	NULL
i	NULL
®	NULL
2	NULL
.	NULL

-	NULL
e0	NULL
}	NULL
-Z	NULL
4	NULL
§	NULL
40	NULL
}	NULL
€	NULL
s	NULL
E	NULL
20	NULL
|-6	NULL
ax	NULL
o	NULL
I	NULL
4	NULL
0.01	NULL
Concentration	NULL
of	NULL
IFNy	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

Fig	NULL
4	NULL
.	NULL

Effect	NULL
of	NULL
IL-10	NULL
on	NULL
IFNy-induced	NULL
assembly	NULL
of	NULL
STAT1	NULL
dimers	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Monocytes	NULL
were	NULL
preincubated	NULL
with	NULL
10	NULL
ng/mL	NULL
of	NULL
IL-10	NULL
for	NULL
90	NULL
minutes	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
IFNy	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

Whole-cell	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
an	NULL
EMSA	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
GRR	NULL
probe	NULL
,	NULL
which	NULL
is	NULL
recognized	NULL
by	NULL
phosphorylated	NULL
STAT1	NULL
.	NULL

The	NULL
upper	NULL
band	NULL
of	NULL
the	NULL
shifted	NULL
complex	NULL
was	NULL
presumed	NULL
to	NULL
be	NULL
multimers	NULL
of	NULL
STAT1	NULL
binding	NULL
to	NULL
the	NULL
probe	NULL
.	NULL

The	NULL
autoradiograph	NULL
represents	NULL
that	NULL
part	NULL
of	NULL
the	NULL
total	NULL
gel	NULL
analyzed	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
with	NULL
GRR	NULL
probe	NULL
was	NULL
performed	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
,	NULL
except	NULL
that	NULL
the	NULL
indicated	NULL
doses	NULL
of	NULL
IFNy	NULL
were	NULL
used	NULL
.	NULL

The	NULL
response	NULL
was	NULL
measured	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
maximum	NULL
response	NULL
of	NULL
cells	NULL
treated	NULL
with	NULL
IFNy	NULL
at	NULL
10	NULL
ng/mL	NULL
.	NULL

Three	NULL
experiments	NULL
were	NULL
performed	NULL
using	NULL
individual	NULL
donors	NULL
,	NULL
and	NULL
the	NULL
data	NULL
are	NULL
presented	NULL
asthe	NULL
mean	NULL
+	NULL
standard	NULL
error	NULL
.	NULL

(	NULL
0	NULL
)	NULL
Treated	NULL
with	NULL
IFNy	NULL
alone	NULL
;	NULL
(	NULL
@	NULL
)	NULL
treated	NULL
with	NULL
IL-10	NULL
and	NULL
IFNy	NULL
.	NULL

ITO	NULL
ET	NULL
AL	NULL
IP	NULL
:	NULL
anti-STAT	NULL
1	NULL
BLOT	NULL
:	NULL
anti-P-Tyr	NULL
3	NULL
eﬂ	NULL
«	NULL
--	NULL
STAT	NULL
BLOT	NULL
:	NULL
anti-STAT	NULL
1	NULL
comme	NULL
«	NULL
pred	NULL
-	NULL
nate	NULL
*	NULL
1	NULL
2	NULL
3	NULL
4	NULL
100	NULL
__	NULL
T	NULL
C	NULL
0	NULL
S	NULL
s	NULL
§	NULL
sel	NULL
D	NULL
o	NULL
£	NULL
a	NULL
’	NULL
_	NULL
(	NULL
2	NULL
a	NULL
C	NULL
.0	NULL
5	NULL
Kes	NULL
.£	NULL
&	NULL
-50	NULL
|-	NULL
0.5-1.0	NULL
2.5	NULL
5.0	NULL
10.0	NULL
(	NULL
n	NULL
=	NULL
7	NULL
)	NULL
(	NULL
n=3	NULL
)	NULL
(	NULL
n=	NULL
3	NULL
)	NULL
(	NULL
n=	NULL
4	NULL
)	NULL
Concentration	NULL
of	NULL
IFNy	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

Fig	NULL
5	NULL
.	NULL

-	NULL
IL-10	NULL
inhibits	NULL
the	NULL
IFNy-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Monocytes	NULL
were	NULL
pretreated	NULL
with	NULL
10	NULL
ng/mL	NULL
of	NULL
IL-10	NULL
for	NULL
60	NULL
minutes	NULL
,	NULL
and	NULL
then	NULL
treated	NULL
with	NULL
0.5	NULL
ng/	NULL
mL	NULL
of	NULL
IFNy	NULL
for	NULL
20	NULL
minutes	NULL
.	NULL

The	NULL
upper	NULL
panel	NULL
represents	NULL
an	NULL
anti-STAT1i	NULL
immunoprecipitation	NULL
blotted	NULL
with	NULL
antiphosphotyrosine	NULL
antibody	NULL
.	NULL

The	NULL
lower	NULL
panel	NULL
represents	NULL
the	NULL
same	NULL
membrane	NULL
reprobed	NULL
with	NULL
anti-STAT1	NULL
.	NULL

The	NULL
slower	NULL
migrating	NULL
band	NULL
is	NULL
tyrosine-phosphorylated	NULL
STATA	NULL
(	NULL
STAT1®	NULL
)	NULL
.	NULL

The	NULL
asterisk	NULL
refers	NULL
to	NULL
a	NULL
lower	NULL
molecular	NULL
weight	NULL
band	NULL
that	NULL
is	NULL
frequently	NULL
observed	NULL
in	NULL
the	NULL
immunoprecipitations	NULL
and	NULL
is	NULL
related	NULL
to	NULL
STAT1	NULL
activation	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Monocytes	NULL
were	NULL
prepared	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
,	NULL
except	NULL
that	NULL
the	NULL
indicated	NULL
doses	NULL
of	NULL
IFNy	NULL
were	NULL
used	NULL
.	NULL

Summary	NULL
of	NULL
laser	NULL
densitometric	NULL
scans	NULL
of	NULL
multiple	NULL
antiphosphotyrosine	NULL
immunoblots	NULL
is	NULL
show	NULL
n.	NULL
The	NULL
values	NULL
for	NULL
percentage	NULL
of	NULL
inhibition	NULL
were	NULL
calculated	NULL
,	NULL
and	NULL
the	NULL
data	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
standard	NULL
deviation	NULL
for	NULL
the	NULL
indicated	NULL
number	NULL
of	NULL
independent	NULL
experiments	NULL
.	NULL

and	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
was	NULL
assessed	NULL
with	NULL
an	NULL
antiphosphotyrosine	NULL
antibody	NULL
.	NULL

There	NULL
was	NULL
substantial	NULL
inhibition	NULL
of	NULL
STAT1	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
both	NULL
the	NULL
91-kD	NULL
and	NULL
a	NULL
lower	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-10	NULL
INHIBITS	NULL
IFN	NULL
SIGNALING	NULL
molecular	NULL
weight	NULL
STAT1	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
asterisk	NULL
)	NULL
were	NULL
markedly	NULL
decreased	NULL
by	NULL
IL-10	NULL
pretreatment	NULL
(	NULL
Fig	NULL
5A	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Because	NULL
the	NULL
preincubation	NULL
of	NULL
monocytes	NULL
with	NULL
vanadate	NULL
,	NULL
a	NULL
phosphotyrosine	NULL
phosphatase	NULL
(	NULL
PTP	NULL
)	NULL
inhibitor	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
IL-10	NULL
inhibition	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
SHP1	NULL
,	NULL
a	NULL
PTP	NULL
,	NULL
induces	NULL
the	NULL
effects	NULL
of	NULL
IL-10	NULL
.	NULL

Moreover	NULL
,	NULL
because	NULL
only	NULL
tyrosine-phosphorylated	NULL
STAT1	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
a	NULL
decrease	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
implies	NULL
an	NULL
IL-10	NULL
event	NULL
must	NULL
occur	NULL
at	NULL
the	NULL
receptor	NULL
.	NULL

Again	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
dose-response	NULL
effect	NULL
of	NULL
the	NULL
inhibition	NULL
,	NULL
such	NULL
that	NULL
at	NULL
higher	NULL
doses	NULL
of	NULL
IFNy	NULL
,	NULL
the	NULL
suppressive	NULL
effects	NULL
of	NULL
IL-10	NULL
were	NULL
much	NULL
less	NULL
evident	NULL
(	NULL
Fig	NULL
5B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
most	NULL
inflammatory	NULL
conditions	NULL
,	NULL
IFNy	NULL
concentrations	NULL
are	NULL
generally	NULL
low	NULL
,	NULL
and	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
IL-10	NULL
is	NULL
marked	NULL
at	NULL
concentrations	NULL
of	NULL
1	NULL
ng/mL	NULL
,	NULL
in	NULL
which	NULL
activation	NULL
of	NULL
genes	NULL
is	NULL
generally	NULL
at	NULL
a	NULL
near	NULL
maximal	NULL
level	NULL
.	NULL

Recently	NULL
,	NULL
a	NULL
series	NULL
of	NULL
genes	NULL
have	NULL
been	NULL
cloned	NULL
that	NULL
are	NULL
known	NULL
to	NULL
inhibit	NULL
cytokine-induced	NULL
activation	NULL
of	NULL
cells	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
To	NULL
determine	NULL
if	NULL
IL-10	NULL
induced	NULL
the	NULL
expression	NULL
of	NULL
any	NULL
of	NULL
these	NULL
genes	NULL
,	NULL
we	NULL
treated	NULL
cells	NULL
with	NULL
IL-10	NULL
and	NULL
isolated	NULL
RNA	NULL
for	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

The	NULL
results	NULL
of	NULL
this	NULL
analysis	NULL
showed	NULL
that	NULL
IL-10	NULL
could	NULL
rapidly	NULL
(	NULL
within	NULL
30	NULL
minutes	NULL
)	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
SOCS3	NULL
gene	NULL
and	NULL
maintain	NULL
its	NULL
expression	NULL
for	NULL
at	NULL
least	NULL
120	NULL
minutes	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
IL-10	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
this	NULL
induction	NULL
of	NULL
SOCS3	NULL
gene	NULL
expression	NULL
by	NULL
IL-10	NULL
were	NULL
consistent	NULL
with	NULL
its	NULL
potential	NULL
role	NULL
in	NULL
counterregulating	NULL
IFN-induced	NULL
STAT1	NULL
activation	NULL
and	NULL
IFN-induced	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
preliminary	NULL
experiments	NULL
,	NULL
we	NULL
found	NULL
that	NULL
IL-10	NULL
did	NULL
not	NULL
upregulate	NULL
expression	NULL
of	NULL
the	NULL
related	NULL
genes	NULL
,	NULL
CIS-1	NULL
,	NULL
SOCS-1	NULL
,	NULL
or	NULL
SOCS-2	NULL
,	NULL
in	NULL
monocytes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
IL-10	NULL
suppresses	NULL
the	NULL
ability	NULL
of	NULL
LPS	NULL
to	NULL
elicit	NULL
increases	NULL
in	NULL
mRNA	NULL
of	NULL
IL-1	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
other	NULL
cytokines	NULL
or	NULL
cytokine	NULL
receptors	NULL
.	NULL
``	NULL

In	NULL
some	NULL
of	NULL
these	NULL
studies	NULL
,	NULL
it	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
IFNy	NULL
to	NULL
enhance	NULL
the	NULL
effects	NULL
of	NULL
LPS	NULL
can	NULL
also	NULL
be	NULL
suppressed	NULL
by	NULL
IL-10.4	NULL
``	NULL
However	NULL
,	NULL
there	NULL
has	NULL
been	NULL
no	NULL
study	NULL
addressing	NULL
whether	NULL
IL-10	NULL
inhibits	NULL
IFNy-	NULL
and	NULL
IFN-stimulated	NULL
early	NULL
response	NULL
genes	NULL
in	NULL
monocytes	NULL
.	NULL

Both	NULL
IFN	NULL
«	NULL
and	NULL
IFNy	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
by	NULL
activating	NULL
STAT	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
either	NULL
GAS	NULL
or	NULL
ISRE	NULL
enhancers	NULL
.	NULL
``	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
IL-10	NULL
can	NULL
inhibit	NULL
the	NULL
induction	NULL
of	NULL
IFN-induced	NULL
genes	NULL
by	NULL
preventing	NULL
the	NULL
assembly	NULL
of	NULL
ISGF3	NULL
and	NULL
+	NULL
IL-10	NULL
poo	NULL
--	NULL
-	NULL
--	NULL
-0	NULL
_	NULL
30	NULL
60	NULL
90	NULL
120	NULL
:	NULL
time	NULL
(	NULL
min	NULL
.	NULL
)	NULL

wn	NULL
ae	NULL
-as	NULL
~	NULL
<	NULL
-S0CS-3	NULL
woul	NULL
aan	NULL
<	NULL
-	NULL
CAPD	NULL
Fig	NULL
6	NULL
.	NULL

-	NULL
IL-10	NULL
induces	NULL
expression	NULL
of	NULL
the	NULL
SOCS3	NULL
gene	NULL
in	NULL
monocytes	NULL
.	NULL

Monocytes	NULL
were	NULL
incubated	NULL
for	NULL
the	NULL
designated	NULL
times	NULL
with	NULL
10	NULL
ng/mL	NULL
of	NULL
IL-10	NULL
and	NULL
then	NULL
processed	NULL
for	NULL
RNA	NULL
isolation	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
was	NULL
performed	NULL
as	NULL
outlined	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

1461	NULL
GRR/GAS	NULL
transcription	NULL
complexes	NULL
.	NULL

The	NULL
suppression	NULL
of	NULL
gene	NULL
expression	NULL
correlates	NULL
with	NULL
the	NULL
IL-10-induced	NULL
inhibition	NULL
of	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
,	NULL
which	NULL
is	NULL
required	NULL
for	NULL
this	NULL
protein	NULL
to	NULL
bind	NULL
DNA	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
SOCS3	NULL
gene	NULL
is	NULL
induced	NULL
by	NULL
IL-10	NULL
and	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
suppression	NULL
of	NULL
STAT1	NULL
phosphorylation	NULL
.	NULL

IL-10	NULL
has	NULL
numerous	NULL
effects	NULL
on	NULL
hematopoietic	NULL
cells	NULL
,	NULL
but	NULL
most	NULL
notable	NULL
is	NULL
its	NULL
association	NULL
with	NULL
the	NULL
development	NULL
of	NULL
Th2	NULL
lympho-cytes	NULL
.	NULL

The	NULL
polarization	NULL
of	NULL
T-cell	NULL
development	NULL
is	NULL
thought	NULL
to	NULL
progress	NULL
from	NULL
a	NULL
ThO	NULL
phase	NULL
to	NULL
either	NULL
a	NULL
Thl	NULL
or	NULL
Th2	NULL
cell	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
various	NULL
ILs.4	NULL
IL-10	NULL
is	NULL
secreted	NULL
by	NULL
Th2	NULL
cells	NULL
,	NULL
and	NULL
once	NULL
secreted	NULL
,	NULL
it	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
inhibition	NULL
of	NULL
monocyte/macrophage	NULL
function	NULL
,	NULL
thereby	NULL
suppressing	NULL
the	NULL
Th1	NULL
phenotype	NULL
.	NULL
``	NULL

Like	NULL
IFNs	NULL
,	NULL
IL-10	NULL
activates	NULL
STAT	NULL
complexes	NULL
.	NULL

``	NULL
``	NULL
``	NULL
``	NULL
``	NULL
34	NULL
Incubation	NULL
of	NULL
monocytes	NULL
with	NULL
IL-10	NULL
activates	NULL
primarily	NULL
STAT3	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
,	NULL
STAT1	NULL
.	NULL
``	NULL

However	NULL
,	NULL
studies	NULL
using	NULL
STAT1-deficient	NULL
mice	NULL
indicated	NULL
that	NULL
STAT3	NULL
is	NULL
important	NULL
for	NULL
IL-10	NULL
inhibition	NULL
of	NULL
LPS-induced	NULL
monocyte	NULL
activation	NULL
.	NULL
``	NULL

Because	NULL
IL-10	NULL
activation	NULL
of	NULL
STATs	NULL
is	NULL
transient	NULL
in	NULL
monocytes	NULL
(	NULL
<	NULL
30	NULL
minutes	NULL
)	NULL
,	NULL
by	NULL
the	NULL
time	NULL
IFNs	NULL
were	NULL
added	NULL
,	NULL
activated	NULL
STAT	NULL
's	NULL
were	NULL
not	NULL
present	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Because	NULL
IL-10	NULL
treatment	NULL
of	NULL
monocytes	NULL
does	NULL
not	NULL
alter	NULL
the	NULL
number	NULL
or	NULL
affinity	NULL
of	NULL
IFN	NULL
cell	NULL
surface	NULL
receptors	NULL
,	NULL
another	NULL
mechanism	NULL
must	NULL
be	NULL
regulated	NULL
by	NULL
which	NULL
IL-10	NULL
inhibits	NULL
IFN-stimulated	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
.	NULL

There	NULL
has	NULL
been	NULL
recently	NULL
discovered	NULL
a	NULL
new	NULL
class	NULL
of	NULL
molecules	NULL
referred	NULL
to	NULL
as	NULL
SOCS	NULL
proteins	NULL
that	NULL
seem	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
cytokines	NULL
and	NULL
then	NULL
act	NULL
as	NULL
negative	NULL
regulators	NULL
to	NULL
inhibit	NULL
signal	NULL
transduction	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
These	NULL
molecules	NULL
possess	NULL
SH2	NULL
domains	NULL
and	NULL
can	NULL
bind	NULL
to	NULL
phosphoty-rosines	NULL
on	NULL
Jaks	NULL
or	NULL
cytokine	NULL
receptors	NULL
.	NULL

Of	NULL
interest	NULL
,	NULL
Jak1	NULL
is	NULL
used	NULL
by	NULL
all	NULL
three	NULL
molecules	NULL
:	NULL
IFN	NULL
«	NULL
,	NULL
IFNy	NULL
,	NULL
and	NULL
IL-10	NULL
.	NULL

There	NULL
does	NULL
seem	NULL
to	NULL
be	NULL
some	NULL
specificity	NULL
with	NULL
regard	NULL
to	NULL
the	NULL
inhibitory	NULL
actions	NULL
of	NULL
SOCS	NULL
,	NULL
because	NULL
only	NULL
SOCS1	NULL
and	NULL
3	NULL
,	NULL
but	NULL
not	NULL
CIS	NULL
(	NULL
an	NULL
inhibitor	NULL
of	NULL
GM-CSF-induced	NULL
STAT5	NULL
)	NULL
,	NULL
were	NULL
able	NULL
to	NULL
inhibit	NULL
growth	NULL
hormone-induced	NULL
STATS	NULL
activation	NULL
.	NULL
``	NULL

Constitutive	NULL
SOCS1	NULL
expression	NULL
in	NULL
transfected	NULL
cells	NULL
was	NULL
shown	NULL
to	NULL
suppress	NULL
IFN	NULL
activation	NULL
.	NULL
``	NULL

''	NULL
No	NULL
studies	NULL
have	NULL
shown	NULL
whether	NULL
IL-10	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
any	NULL
SOCS	NULL
genes	NULL
.	NULL

Experiments	NULL
to	NULL
detect	NULL
association	NULL
between	NULL
Jaks	NULL
and	NULL
SOCS	NULL
proteins	NULL
have	NULL
been	NULL
very	NULL
difficult	NULL
using	NULL
available	NULL
antibodies	NULL
.	NULL

Only	NULL
very	NULL
high	NULL
expression	NULL
of	NULL
a	NULL
transiently	NULL
transfected	NULL
myc-JAB	NULL
(	NULL
CIS-like	NULL
)	NULL
gene	NULL
and	NULL
Jak2	NULL
(	NULL
that	NULL
is	NULL
constitutively	NULL
tyrosine	NULL
phosphorylated	NULL
)	NULL
allowed	NULL
coimmuno-precipitation	NULL
of	NULL
these	NULL
two	NULL
proteins	NULL
.	NULL
``	NULL

''	NULL
In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
do	NULL
show	NULL
that	NULL
IL-10	NULL
can	NULL
rapidly	NULL
(	NULL
30	NULL
minutes	NULL
)	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
SOCS3	NULL
,	NULL
possibly	NULL
through	NULL
its	NULL
ability	NULL
to	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
.	NULL

Whether	NULL
STAT3-stimulated	NULL
expression	NULL
of	NULL
SOCS3	NULL
accounts	NULL
for	NULL
the	NULL
IL-10	NULL
inhibition	NULL
of	NULL
STAT1	NULL
tyrosine	NULL
phosphorylation	NULL
by	NULL
IFNs	NULL
is	NULL
not	NULL
yet	NULL
known	NULL
.	NULL

Another	NULL
well-documented	NULL
mechanism	NULL
to	NULL
inhibit	NULL
cytokine	NULL
signaling	NULL
is	NULL
the	NULL
activation	NULL
of	NULL
tyrosine	NULL
phosphatases	NULL
that	NULL
inacti-vate	NULL
Jaks	NULL
by	NULL
dephosphorylation	NULL
.	NULL

Ligand-stimulated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
can	NULL
be	NULL
inhibited	NULL
by	NULL
targeting	NULL
the	NULL
phosphatase	NULL
SHP1	NULL
(	NULL
PTP-1C	NULL
)	NULL
to	NULL
the	NULL
receptor	NULL
,	NULL
resulting	NULL
in	NULL
dephosphorylation	NULL
of	NULL
Jak2.45	NULL
``	NULL
``	NULL
Although	NULL
we	NULL
have	NULL
found	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
Jakl	NULL
is	NULL
unchanged	NULL
after	NULL
IL-10	NULL
treatment	NULL
,	NULL
under	NULL
the	NULL
current	NULL
culture	NULL
conditions	NULL
we	NULL
have	NULL
not	NULL
been	NULL
able	NULL
to	NULL
quantitate	NULL
its	NULL
degree	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
,	NULL
either	NULL
by	NULL
in	NULL
vitro	NULL
kinase	NULL
assay	NULL
or	NULL
by	NULL
immunoblotting	NULL
with	NULL
antiphospho-tyrosine	NULL
.	NULL

When	NULL
the	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
vanadate	NULL
,	NULL
a	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1462	NULL
tyrosine	NULL
phosphatase	NULL
inhibitor	NULL
,	NULL
there	NULL
was	NULL
no	NULL
evidence	NULL
that	NULL
the	NULL
inhibitory	NULL
actions	NULL
of	NULL
IL-10	NULL
were	NULL
altered	NULL
,	NULL
suggesting	NULL
that	NULL
IL-10-regulated	NULL
phosphatase	NULL
activity	NULL
is	NULL
not	NULL
involved	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

One	NULL
common	NULL
theme	NULL
throughout	NULL
the	NULL
study	NULL
has	NULL
been	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
dose	NULL
of	NULL
IFN	NULL
on	NULL
the	NULL
inhibitory	NULL
action	NULL
of	NULL
IL-10	NULL
.	NULL

At	NULL
high	NULL
doses	NULL
of	NULL
either	NULL
IFNa	NULL
«	NULL
or	NULL
IFNy	NULL
,	NULL
the	NULL
inhibitory	NULL
action	NULL
of	NULL
IL-10	NULL
is	NULL
reduced	NULL
.	NULL

At	NULL
lower	NULL
doses	NULL
of	NULL
IFN	NULL
,	NULL
less	NULL
STAT1	NULL
is	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-10	NULL
,	NULL
suggesting	NULL
the	NULL
possibility	NULL
that	NULL
an	NULL
event	NULL
may	NULL
be	NULL
occurring	NULL
at	NULL
the	NULL
plasma	NULL
membrane	NULL
that	NULL
is	NULL
regulated	NULL
by	NULL
IL-10	NULL
.	NULL

We	NULL
and	NULL
others	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
Jaks	NULL
are	NULL
associated	NULL
with	NULL
IFN	NULL
receptors	NULL
,	NULL
and	NULL
STAT1	NULL
migrates	NULL
to	NULL
the	NULL
receptor	NULL
once	NULL
IFN	NULL
binds	NULL
.	NULL

Because	NULL
the	NULL
major	NULL
event	NULL
that	NULL
determines	NULL
the	NULL
amount	NULL
of	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
is	NULL
the	NULL
concentration	NULL
of	NULL
IFN	NULL
binding	NULL
to	NULL
its	NULL
receptor	NULL
,	NULL
it	NULL
seems	NULL
reasonable	NULL
to	NULL
hypothesize	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
IL-10	NULL
is	NULL
to	NULL
disrupt	NULL
this	NULL
multimolecular	NULL
complex	NULL
,	NULL
such	NULL
that	NULL
the	NULL
efficiency	NULL
of	NULL
STAT1	NULL
tyrosine	NULL
phosphorylation	NULL
is	NULL
diminished	NULL
.	NULL

IL-10	NULL
induction	NULL
of	NULL
SOCS3	NULL
would	NULL
be	NULL
one	NULL
such	NULL
mechanism	NULL
to	NULL
account	NULL
for	NULL
the	NULL
observed	NULL
inhibitory	NULL
actions	NULL
of	NULL
IL-10	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
IL-10	NULL
can	NULL
inhibit	NULL
the	NULL
induction	NULL
of	NULL
certain	NULL
IFN-induced	NULL
genes	NULL
.	NULL

ICAM-1	NULL
was	NULL
only	NULL
induced	NULL
by	NULL
IFNy	NULL
and	NULL
showed	NULL
good	NULL
IL-10-induced	NULL
inhibition	NULL
.	NULL

The	NULL
inhibition	NULL
by	NULL
IL-10	NULL
was	NULL
fairly	NULL
consistent	NULL
among	NULL
the	NULL
genes	NULL
,	NULL
except	NULL
for	NULL
IRF-1	NULL
.	NULL

Although	NULL
IRF-1	NULL
has	NULL
a	NULL
GAS	NULL
motif	NULL
that	NULL
drives	NULL
this	NULL
gene	NULL
,	NULL
there	NULL
was	NULL
only	NULL
a	NULL
minimal	NULL
effect	NULL
by	NULL
IL-10.4°	NULL
This	NULL
gene	NULL
was	NULL
readily	NULL
induced	NULL
by	NULL
IFNy	NULL
in	NULL
monocytes	NULL
,	NULL
but	NULL
no	NULL
induction	NULL
was	NULL
observed	NULL
with	NULL
IFNa	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

There	NULL
are	NULL
several	NULL
other	NULL
elements	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
this	NULL
gene	NULL
that	NULL
may	NULL
override	NULL
IFNy	NULL
activation	NULL
through	NULL
its	NULL
GAS	NULL
element	NULL
,	NULL
if	NULL
this	NULL
enhancer	NULL
is	NULL
inhibited	NULL
by	NULL
incubation	NULL
of	NULL
cells	NULL
with	NULL
IL-10	NULL
.	NULL

These	NULL
include	NULL
Spl	NULL
and	NULL
NFkB	NULL
binding	NULL
sites	NULL
.	NULL

Recently	NULL
,	NULL
mice	NULL
deficient	NULL
in	NULL
the	NULL
IFN-induced-gene	NULL
,	NULL
double-stranded	NULL
RNA-activated	NULL
Ser/Thr	NULL
protein	NULL
kinase	NULL
(	NULL
PKR	NULL
)	NULL
were	NULL
studied	NULL
for	NULL
their	NULL
responsiveness	NULL
to	NULL
IFNy	NULL
.	NULL
``	NULL

PKR	NULL
is	NULL
important	NULL
for	NULL
IFN-induced	NULL
activation	NULL
of	NULL
NFB	NULL
.	NULL

Cells	NULL
from	NULL
these	NULL
mice	NULL
showed	NULL
no	NULL
IFNy-induced	NULL
expression	NULL
of	NULL
IRF-1-promoter-reporter	NULL
constructs	NULL
.	NULL

This	NULL
response	NULL
was	NULL
restored	NULL
on	NULL
transfection	NULL
with	NULL
wild-type	NULL
PKR	NULL
,	NULL
suggesting	NULL
that	NULL
NFkB	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
mediating	NULL
the	NULL
expression	NULL
of	NULL
IRF-1	NULL
.	NULL

It	NULL
was	NULL
recently	NULL
shown	NULL
that	NULL
in	NULL
human	NULL
monocytes	NULL
,	NULL
there	NULL
was	NULL
no	NULL
inhibition	NULL
of	NULL
GAS	NULL
binding	NULL
activity	NULL
or	NULL
STAT1	NULL
tyrosine	NULL
phosphorylation	NULL
after	NULL
pretreatment	NULL
with	NULL
IL-10	NULL
in	NULL
a	NULL
study	NULL
of	NULL
ICAM-1	NULL
induction	NULL
by	NULL
IFNy	NULL
.	NULL
``	NULL

One	NULL
possible	NULL
reason	NULL
for	NULL
the	NULL
discrepancy	NULL
between	NULL
our	NULL
results	NULL
is	NULL
the	NULL
differences	NULL
in	NULL
the	NULL
way	NULL
the	NULL
monocytes	NULL
were	NULL
prepared	NULL
.	NULL

In	NULL
Song	NULL
et	NULL
al	NULL
,	NULL
``	NULL
the	NULL
monocytes	NULL
were	NULL
passed	NULL
over	NULL
Ficoll-Hypaque	NULL
and	NULL
then	NULL
allowed	NULL
to	NULL
adhere	NULL
for	NULL
1.5	NULL
hours	NULL
in	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

This	NULL
process	NULL
allows	NULL
for	NULL
adherence	NULL
of	NULL
some	NULL
B	NULL
cells	NULL
and	NULL
possibly	NULL
even	NULL
some	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
monocyte	NULL
preparations	NULL
were	NULL
generally	NULL
only	NULL
85	NULL
%	NULL
pure	NULL
.	NULL

Moreover	NULL
,	NULL
Song	NULL
et	NULL
al	NULL
``	NULL
``	NULL
used	NULL
a	NULL
concentration	NULL
of	NULL
IFNy	NULL
(	NULL
10	NULL
ng/mL	NULL
)	NULL
that	NULL
was	NULL
10-fold	NULL
higher	NULL
than	NULL
the	NULL
maximal	NULL
concentrations	NULL
of	NULL
IFNy	NULL
we	NULL
used	NULL
to	NULL
observe	NULL
the	NULL
effects	NULL
described	NULL
in	NULL
this	NULL
report	NULL
.	NULL
``	NULL

''	NULL
We	NULL
observed	NULL
a	NULL
decrease	NULL
in	NULL
IFN-induced	NULL
STAT	NULL
binding	NULL
to	NULL
two	NULL
distinct	NULL
elements	NULL
and	NULL
a	NULL
decrease	NULL
in	NULL
the	NULL
corresponding	NULL
STAT1	NULL
tyrosine	NULL
phosphorylation	NULL
for	NULL
both	NULL
IFN	NULL
«	NULL
and	NULL
IFNy	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
,	NULL
for	NULL
cells	NULL
isolated	NULL
by	NULL
our	NULL
method	NULL
with	NULL
minimal	NULL
handling	NULL
and	NULL
more	NULL
physiological	NULL
concentrations	NULL
of	NULL
IFN	NULL
,	NULL
incubation	NULL
with	NULL
IL-10	NULL
inhibits	NULL
IFN-induced	NULL
gene	NULL
activation	NULL
by	NULL
preventing	NULL
the	NULL
phosphorylation	NULL
of	NULL
STAT1	NULL
that	NULL
may	NULL
occur	NULL
through	NULL
activation	NULL
of	NULL
a	NULL
new	NULL
set	NULL
of	NULL
genes	NULL
that	NULL
encode	NULL
for	NULL
proteins	NULL
that	NULL
ITO	NULL
ET	NULL
AL	NULL
suppress	NULL
continued	NULL
cytokine	NULL
activation	NULL
.	NULL

The	NULL
availability	NULL
of	NULL
antibodies	NULL
to	NULL
these	NULL
molecules	NULL
will	NULL
enable	NULL
further	NULL
characterization	NULL
of	NULL
their	NULL
mechanism	NULL
of	NULL
action	NULL
.	NULL

Our	NULL
findings	NULL
define	NULL
an	NULL
important	NULL
mechanism	NULL
by	NULL
which	NULL
IL-10	NULL
can	NULL
antagonize	NULL
IFN-induced	NULL
gene	NULL
expression	NULL
in	NULL
monocytes	NULL
.	NULL

ACKNOWLEDGMENT	NULL
The	NULL
authors	NULL
thank	NULL
Dr	NULL
D.	NULL
Hilton	NULL
(	NULL
Walter	NULL
and	NULL
Eliza	NULL
Hall	NULL
Institute	NULL
,	NULL
Parkville	NULL
,	NULL
Australia	NULL
)	NULL
for	NULL
providing	NULL
the	NULL
SOCS	NULL
cDNAs	NULL
;	NULL
Genentech	NULL
,	NULL
Inc	NULL
(	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
for	NULL
IFNy	NULL
;	NULL
Roche	NULL
,	NULL
Inc	NULL
(	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
for	NULL
IFN	NULL
;	NULL
and	NULL
Schering-Plough	NULL
,	NULL
Inc	NULL
(	NULL
Kenilworth	NULL
,	NULL
NJ	NULL
)	NULL
for	NULL
IL-10	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Hagenbeck	NULL
A	NULL
,	NULL
Carde	NULL
P	NULL
,	NULL
Meerwaldt	NULL
JH	NULL
,	NULL
Somers	NULL
R	NULL
,	NULL
Thomas	NULL
J	NULL
,	NULL
De	NULL
Bock	NULL
R	NULL
,	NULL
Raemaekers	NULL
JM	NULL
,	NULL
van	NULL
Hoof	NULL
A	NULL
,	NULL
De	NULL
W	NULL
:	NULL
Human	NULL
recombinant	NULL
interferon	NULL
alfa-2a	NULL
in	NULL
patients	NULL
with	NULL
stages	NULL
III	NULL
and	NULL
IV	NULL
low-grade	NULL
malignant	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
.	NULL

European	NULL
Organization	NULL
for	NULL
Research	NULL
and	NULL
Treatment	NULL
of	NULL
Cancer	NULL
Lymphoma	NULL
Cooperative	NULL
Group	NULL
.	NULL

J	NULL
Clin	NULL
Oncol	NULL
16:41	NULL
,	NULL
1998	NULL
2	NULL
.	NULL

Zinzani	NULL
PL	NULL
,	NULL
Bendandi	NULL
M	NULL
,	NULL
Magagnoli	NULL
M	NULL
,	NULL
Rondelli	NULL
D	NULL
,	NULL
de	NULL
Vivo	NULL
A	NULL
,	NULL
Benni	NULL
M	NULL
,	NULL
Zamagni	NULL
E	NULL
,	NULL
Cavo	NULL
M	NULL
,	NULL
Tura	NULL
S	NULL
:	NULL
Results	NULL
of	NULL
a	NULL
fludarabine	NULL
induction	NULL
and	NULL
alpha-interferon	NULL
maintenance	NULL
protocol	NULL
in	NULL
pretreated	NULL
patients	NULL
with	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
and	NULL
low-grade	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
.	NULL

Eur	NULL
J	NULL
Haematol	NULL
59:82	NULL
,	NULL
1997	NULL
3	NULL
.	NULL

Tamm	NULL
I	NULL
,	NULL
Grimme	NULL
H	NULL
,	NULL
Bergen	NULL
E	NULL
,	NULL
Simon	NULL
JC	NULL
,	NULL
Schopf	NULL
E	NULL
,	NULL
Mertelsmann	NULL
R	NULL
,	NULL
Lindemann	NULL
A	NULL
,	NULL
Brennscheidt	NULL
U	NULL
:	NULL
Dacarbazine	NULL
and	NULL
interferon	NULL
alpha	NULL
for	NULL
stage	NULL
IV	NULL
malignant	NULL
melanoma	NULL
.	NULL

Oncology	NULL
54:270	NULL
,	NULL
1997	NULL
4	NULL
.	NULL

Biron	NULL
C	NULL
,	NULL
Gazzinelli	NULL
R	NULL
:	NULL
Effects	NULL
of	NULL
IL-12	NULL
on	NULL
immune	NULL
responses	NULL
to	NULL
microbial	NULL
infections	NULL
:	NULL
A	NULL
key	NULL
mediator	NULL
in	NULL
regulating	NULL
disease	NULL
outcome	NULL
.	NULL

Curr	NULL
Opin	NULL
Immunol	NULL
7:485	NULL
,	NULL
1995	NULL
5	NULL
.	NULL

Petricoin	NULL
E	NULL
,	NULL
David	NULL
M	NULL
,	NULL
Fang	NULL
H	NULL
,	NULL
Grimley	NULL
P	NULL
,	NULL
Larner	NULL
AC	NULL
,	NULL
Vande	NULL
Pol	NULL
S	NULL
:	NULL
Human	NULL
cancer	NULL
cell	NULL
lines	NULL
express	NULL
a	NULL
negative	NULL
transcriptional	NULL
regulator	NULL
of	NULL
the	NULL
interferon	NULL
regulatory	NULL
factor	NULL
family	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:1477	NULL
,	NULL
1994	NULL
6	NULL
.	NULL

Finbloom	NULL
DS	NULL
,	NULL
Larner	NULL
AC	NULL
,	NULL
Nakagawa	NULL
Y	NULL
,	NULL
Hoover	NULL
DL	NULL
:	NULL
Culture	NULL
of	NULL
human	NULL
monocytes	NULL
in	NULL
granulocyte-macrophage	NULL
CSF	NULL
results	NULL
in	NULL
enhancement	NULL
of	NULL
interferon	NULL
y	NULL
receptors	NULL
but	NULL
suppression	NULL
of	NULL
IFNy-induced	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
,	NULL
IP-10	NULL
.	NULL

J	NULL
Immunol	NULL
150:2383	NULL
,	NULL
1993	NULL
7	NULL
.	NULL

O'Garra	NULL
A	NULL
,	NULL
Murphy	NULL
K	NULL
:	NULL
Role	NULL
of	NULL
cytokines	NULL
in	NULL
determining	NULL
T-lymphocyte	NULL
function	NULL
.	NULL

Curr	NULL
Opin	NULL
Immunol	NULL
6:458	NULL
,	NULL
1994	NULL
8	NULL
.	NULL

Locksley	NULL
RM	NULL
,	NULL
Scott	NULL
P	NULL
:	NULL
Helper	NULL
T	NULL
cell	NULL
subsets	NULL
in	NULL
mouse	NULL
leishmani-asis	NULL
:	NULL
Induction	NULL
,	NULL
expansion	NULL
and	NULL
effector	NULL
function	NULL
.	NULL

Immunol	NULL
Today	NULL
12:58	NULL
,	NULL
1991	NULL
9	NULL
.	NULL

Katsikis	NULL
PD	NULL
,	NULL
Chu	NULL
CQ	NULL
,	NULL
Brennan	NULL
FM	NULL
,	NULL
Maini	NULL
RN	NULL
,	NULL
Feldmann	NULL
M	NULL
:	NULL
Immunoregulatory	NULL
role	NULL
of	NULL
interleukin	NULL
10	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
179:1517	NULL
,	NULL
1994	NULL
10	NULL
.	NULL

Powrie	NULL
F	NULL
,	NULL
Leach	NULL
MW	NULL
,	NULL
Mauze	NULL
S	NULL
,	NULL
Monon	NULL
S	NULL
,	NULL
Caddle	NULL
LB	NULL
,	NULL
Coffman	NULL
RL	NULL
:	NULL
Inhibition	NULL
of	NULL
Th1	NULL
responses	NULL
prevents	NULL
inflammatory	NULL
bowel	NULL
disease	NULL
in	NULL
scid	NULL
mice	NULL
reconstituted	NULL
with	NULL
CD45RB	NULL
``	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

Immunity	NULL
1:553	NULL
,	NULL
1994	NULL
11	NULL
.	NULL

Larner	NULL
AC	NULL
,	NULL
Petricoin	NULL
EF	NULL
,	NULL
Nakagawa	NULL
Y	NULL
,	NULL
Finbloom	NULL
DS	NULL
:	NULL
IL-4	NULL
attenuates	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
both	NULL
IFNa	NULL
«	NULL
and	NULL
IFNy	NULL
induced	NULL
cellular	NULL
gene	NULL
expression	NULL
in	NULL
monocytes	NULL
and	NULL
monocytic	NULL
cell	NULL
lines	NULL
.	NULL

J	NULL
Immunol	NULL
150:1944	NULL
,	NULL
1993	NULL
12	NULL
.	NULL

Dickensheets	NULL
HL	NULL
,	NULL
Donnelly	NULL
RP	NULL
:	NULL
IFN-y	NULL
and	NULL
IL-10	NULL
inhibit	NULL
induction	NULL
of	NULL
IL-1	NULL
receptor	NULL
type-1	NULL
and	NULL
type-II	NULL
gene	NULL
expression	NULL
by	NULL
IL-4	NULL
and	NULL
IL-13	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

J	NULL
Immunol	NULL
159:6226	NULL
,	NULL
1997	NULL
13	NULL
.	NULL

De	NULL
Waal	NULL
Malefyt	NULL
R	NULL
,	NULL
Abrans	NULL
J	NULL
,	NULL
Bennett	NULL
B	NULL
,	NULL
Figdor	NULL
C	NULL
,	NULL
de	NULL
Vries	NULL
J	NULL
:	NULL
IL-10	NULL
inhibits	NULL
cytokine	NULL
synthesis	NULL
by	NULL
human	NULL
monocytes	NULL
:	NULL
An	NULL
autoregula-tory	NULL
role	NULL
of	NULL
IL-10	NULL
produced	NULL
by	NULL
monocytes	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
1741209	NULL
,	NULL
1991	NULL
14	NULL
.	NULL

Finbloom	NULL
DS	NULL
,	NULL
Larner	NULL
AC	NULL
:	NULL
Induction	NULL
of	NULL
early	NULL
response	NULL
genes	NULL
by	NULL
interferons	NULL
,	NULL
interleukins	NULL
,	NULL
and	NULL
growth	NULL
factors	NULL
by	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
latent	NULL
transcription	NULL
factors	NULL
:	NULL
Implications	NULL
for	NULL
inflammatory	NULL
diseases	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
38:877	NULL
,	NULL
1995	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

IL-10	NULL
INHIBITS	NULL
IFN	NULL
SIGNALING	NULL
15	NULL
.	NULL

Finbloom	NULL
DS	NULL
,	NULL
Winestock	NULL
KD	NULL
:	NULL
IL-10	NULL
induces	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
tyk2	NULL
and	NULL
Jakl	NULL
and	NULL
the	NULL
differential	NULL
assembly	NULL
of	NULL
STAT1a	NULL
and	NULL
STAT3	NULL
complexes	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
and	NULL
monocytes	NULL
.	NULL

J	NULL
Immunol	NULL
155:1079	NULL
,	NULL
1995	NULL
16	NULL
.	NULL

Lamer	NULL
AC	NULL
,	NULL
Finbloom	NULL
DS	NULL
:	NULL
Protein	NULL
tyrosine	NULL
phosphorylation	NULL
as	NULL
a	NULL
mechanism	NULL
which	NULL
regulates	NULL
cytokine	NULL
activation	NULL
of	NULL
early	NULL
response	NULL
genes	NULL
.	NULL

Biochim	NULL
Biophys	NULL
Acta	NULL
1266:278	NULL
,	NULL
1995	NULL
17	NULL
.	NULL

Lamer	NULL
AC	NULL
,	NULL
David	NULL
M	NULL
,	NULL
Feldman	NULL
GM	NULL
,	NULL
Igarashi	NULL
K	NULL
,	NULL
Hackett	NULL
RH	NULL
,	NULL
Webb	NULL
DAS	NULL
,	NULL
Sweitzer	NULL
SM	NULL
,	NULL
Petricoin	NULL
EF	NULL
III	NULL
,	NULL
Finbloom	NULL
DS	NULL
:	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
DNA	NULL
binding	NULL
proteins	NULL
by	NULL
multiple	NULL
cytokines	NULL
.	NULL

Science	NULL
261:1730	NULL
,	NULL
1993	NULL
18	NULL
.	NULL

Akai	NULL
H	NULL
,	NULL
Larner	NULL
AC	NULL
:	NULL
Phorbol	NULL
ester-mediated	NULL
down-regulation	NULL
of	NULL
an	NULL
interferon-inducible	NULL
gene	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
264:3252	NULL
,	NULL
1989	NULL
19	NULL
.	NULL

Luster	NULL
AD	NULL
,	NULL
Unkeless	NULL
JC	NULL
,	NULL
Ravetch	NULL
JV	NULL
:	NULL
y-Interferon	NULL
transcription-ally	NULL
regulates	NULL
an	NULL
early-response	NULL
gene	NULL
containing	NULL
homology	NULL
to	NULL
platelet	NULL
proteins	NULL
.	NULL

Nature	NULL
315:672	NULL
,	NULL
1985	NULL
20	NULL
.	NULL

Akai	NULL
H	NULL
,	NULL
Larner	NULL
AC	NULL
:	NULL
Characterization	NULL
of	NULL
two	NULL
independent	NULL
mechanisms	NULL
by	NULL
which	NULL
interferon-induced	NULL
gene	NULL
expression	NULL
is	NULL
down	NULL
regulated	NULL
.	NULL

Cell	NULL
Regul	NULL
1:707	NULL
,	NULL
1990	NULL
21	NULL
.	NULL

Cheng	NULL
YE	NULL
,	NULL
Patterson	NULL
CE	NULL
,	NULL
Stacheli	NULL
P	NULL
:	NULL
Interferon-induced	NULL
ate-binding	NULL
proteins	NULL
lack	NULL
an	NULL
N	NULL
(	NULL
T	NULL
)	NULL
KXD	NULL
concensus	NULL
motif	NULL
and	NULL
bind	NULL
GMP	NULL
in	NULL
addition	NULL
to	NULL
GDP	NULL
AND	NULL
GTP	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
11:4717	NULL
,	NULL
1991	NULL
22	NULL
.	NULL

Piechaczyk	NULL
M	NULL
,	NULL
Blanchard	NULL
JM	NULL
,	NULL
Marty	NULL
L	NULL
,	NULL
Dani	NULL
C	NULL
,	NULL
Panabicres	NULL
F	NULL
,	NULL
El	NULL
Sabouty	NULL
S	NULL
,	NULL
Fort	NULL
P	NULL
,	NULL
Jeanteur	NULL
P	NULL
:	NULL
Post-transcriptional	NULL
regulation	NULL
of	NULL
glyceraldehyde-3-phosphate-dehydrogenase	NULL
gene	NULL
expression	NULL
in	NULL
rat	NULL
tis-sues	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
12:6951	NULL
,	NULL
1984	NULL
23	NULL
.	NULL

Chomezynski	NULL
P	NULL
,	NULL
Sacchi	NULL
N	NULL
:	NULL
Single-step	NULL
method	NULL
of	NULL
RNA	NULL
isolation	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
Biochem	NULL
162:156	NULL
,	NULL
1987	NULL
24	NULL
.	NULL

Hilton	NULL
DJ	NULL
,	NULL
Richardson	NULL
RT	NULL
,	NULL
Alexander	NULL
WS	NULL
,	NULL
Viney	NULL
EM	NULL
,	NULL
Willson	NULL
TA	NULL
,	NULL
Sprigg	NULL
NS	NULL
,	NULL
Starr	NULL
R	NULL
,	NULL
Nicholson	NULL
SE	NULL
,	NULL
Metcalf	NULL
D	NULL
,	NULL
Nicola	NULL
NA	NULL
:	NULL
Twenty	NULL
proteins	NULL
containing	NULL
a	NULL
C-terminal	NULL
SOCS	NULL
box	NULL
form	NULL
five	NULL
structural	NULL
classes	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
95:114	NULL
,	NULL
1998	NULL
25	NULL
.	NULL

Feinberg	NULL
AP	NULL
,	NULL
Vogelstein	NULL
B	NULL
:	NULL
A	NULL
technique	NULL
for	NULL
radiolabeling	NULL
DNA	NULL
restriction	NULL
endonuclease	NULL
fragments	NULL
to	NULL
high	NULL
specific	NULL
activity	NULL
.	NULL

Anal	NULL
Biochem	NULL
132:6	NULL
,	NULL
1983	NULL
26	NULL
.	NULL

Pearse	NULL
RN	NULL
,	NULL
Feinman	NULL
R	NULL
,	NULL
Ravetch	NULL
JV	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
gene	NULL
encoding	NULL
the	NULL
high	NULL
affinity	NULL
IgG	NULL
receptor	NULL
:	NULL
Transcriptional	NULL
induction	NULL
by	NULL
y-interferon	NULL
is	NULL
mediated	NULL
through	NULL
common	NULL
DNA	NULL
response	NULL
elements	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:11305	NULL
,	NULL
1991	NULL
27	NULL
.	NULL

Wilson	NULL
KC	NULL
,	NULL
Finbloom	NULL
DS	NULL
:	NULL
Interferon	NULL
y	NULL
rapidly	NULL
induces	NULL
in	NULL
human	NULL
monocytes	NULL
a	NULL
DNA-binding	NULL
factor	NULL
that	NULL
recognizes	NULL
the	NULL
y	NULL
response	NULL
region	NULL
within	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
gene	NULL
for	NULL
the	NULL
high-affinity	NULL
Foy	NULL
receptor	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
89:11964	NULL
,	NULL
1992	NULL
28	NULL
.	NULL

Meraz	NULL
MA	NULL
,	NULL
White	NULL
JM	NULL
,	NULL
Sheehan	NULL
KC	NULL
,	NULL
Bach	NULL
EA	NULL
,	NULL
Rodig	NULL
SJ	NULL
,	NULL
Dighe	NULL
AS	NULL
,	NULL
Kaplan	NULL
DH	NULL
,	NULL
Riley	NULL
JK	NULL
,	NULL
Greenlund	NULL
AC	NULL
,	NULL
Campbell	NULL
D	NULL
,	NULL
Carver-Moore	NULL
K	NULL
,	NULL
DuBois	NULL
RN	NULL
,	NULL
Clark	NULL
R	NULL
,	NULL
Aguet	NULL
M	NULL
,	NULL
Schreiber	NULL
RD	NULL
:	NULL
Targeted	NULL
disruption	NULL
of	NULL
the	NULL
Statl	NULL
gene	NULL
in	NULL
mice	NULL
reveals	NULL
unexpected	NULL
physiologic	NULL
specificity	NULL
in	NULL
the	NULL
JAK-STAT	NULL
signaling	NULL
pathway	NULL
.	NULL

Cell	NULL
84:431	NULL
,	NULL
1996	NULL
29	NULL
.	NULL

Luster	NULL
AD	NULL
,	NULL
Greenberg	NULL
SM	NULL
,	NULL
Leder	NULL
P	NULL
:	NULL
The	NULL
IP-10	NULL
chemokine	NULL
binds	NULL
to	NULL
a	NULL
specific	NULL
cell	NULL
surface	NULL
heparin	NULL
sulfate	NULL
site	NULL
shared	NULL
with	NULL
platelet	NULL
factor	NULL
4	NULL
and	NULL
inhibits	NULL
endothelial	NULL
cell	NULL
proliferation	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
182:219	NULL
,	NULL
1995	NULL
30	NULL
.	NULL

Sgadari	NULL
C	NULL
,	NULL
Angiolillo	NULL
AL	NULL
,	NULL
Cherney	NULL
BW	NULL
,	NULL
Pike	NULL
SE	NULL
,	NULL
Farber	NULL
JM	NULL
,	NULL
Koniaris	NULL
LG	NULL
,	NULL
Vanguri	NULL
P	NULL
,	NULL
Burd	NULL
PR	NULL
,	NULL
Sheikh	NULL
N	NULL
,	NULL
Gupta	NULL
G	NULL
,	NULL
Teruya-Feldstein	NULL
J	NULL
,	NULL
Tosato	NULL
G	NULL
:	NULL
Interferon-inducible	NULL
protein-10	NULL
identified	NULL
as	NULL
a	NULL
mediator	NULL
of	NULL
tumor	NULL
necrosis	NULL
in	NULL
vivo	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
93:13791	NULL
,	NULL
1996	NULL
31	NULL
.	NULL

Xia	NULL
Y	NULL
,	NULL
Pauza	NULL
ME	NULL
,	NULL
Feng	NULL
L	NULL
,	NULL
Lo	NULL
D	NULL
:	NULL
RelB	NULL
regulation	NULL
of	NULL
chemokine	NULL
expression	NULL
modulates	NULL
local	NULL
inflammation	NULL
.	NULL

Am	NULL
J	NULL
Pathol	NULL
151:375	NULL
,	NULL
1997	NULL
32	NULL
.	NULL

Terol	NULL
MJ	NULL
,	NULL
Lopez-Guillermo	NULL
A	NULL
,	NULL
Bosch	NULL
F	NULL
,	NULL
Villamor	NULL
N	NULL
,	NULL
Cid	NULL
MC	NULL
,	NULL
Rozman	NULL
C	NULL
,	NULL
Campo	NULL
E	NULL
,	NULL
Montserrat	NULL
E	NULL
:	NULL
Expression	NULL
of	NULL
the	NULL
adhesyion	NULL
molecule	NULL
ICAM-1	NULL
in	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
:	NULL
Relationship	NULL
with	NULL
1463	NULL
tumor	NULL
dissemination	NULL
and	NULL
prognostic	NULL
importance	NULL
.	NULL

J	NULL
Clin	NULL
Oncol	NULL
16:35	NULL
,	NULL
1998	NULL
33	NULL
.	NULL

Croft	NULL
M	NULL
,	NULL
Dubey	NULL
C	NULL
:	NULL
Accessory	NULL
molecule	NULL
and	NULL
costimulation	NULL
requirements	NULL
for	NULL
CD4	NULL
T	NULL
cell	NULL
response	NULL
.	NULL

Crit	NULL
Rev	NULL
Immunol	NULL
17:89	NULL
,	NULL
1997	NULL
34	NULL
.	NULL

Song	NULL
S	NULL
,	NULL
Ling-Hu	NULL
H	NULL
,	NULL
Roebuck	NULL
KA	NULL
,	NULL
Rabbi	NULL
MF	NULL
,	NULL
Donnelly	NULL
RP	NULL
,	NULL
Finnegan	NULL
A	NULL
:	NULL
Interleukin-10	NULL
inhibits	NULL
interferon-gamma-induced	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
gene	NULL
transcription	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Blood	NULL
89:4461	NULL
,	NULL
1997	NULL
35	NULL
.	NULL

Eilers	NULL
A	NULL
,	NULL
Seegert	NULL
D	NULL
,	NULL
Schindler	NULL
C	NULL
,	NULL
Baccarini	NULL
M	NULL
,	NULL
Decker	NULL
T	NULL
:	NULL
The	NULL
response	NULL
of	NULL
gamma	NULL
interferon	NULL
activation	NULL
factor	NULL
is	NULL
under	NULL
developmental	NULL
control	NULL
in	NULL
cells	NULL
of	NULL
the	NULL
macrophage	NULL
lineage	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:3245	NULL
,	NULL
1993	NULL
36	NULL
.	NULL

Starr	NULL
R	NULL
,	NULL
Willson	NULL
TA	NULL
,	NULL
Viney	NULL
EM	NULL
,	NULL
Murray	NULL
LJL	NULL
,	NULL
Rayner	NULL
RJR	NULL
,	NULL
Jenkin	NULL
BJ	NULL
,	NULL
Gonda	NULL
TJ	NULL
,	NULL
Alexander	NULL
WS	NULL
,	NULL
Metcalf	NULL
D	NULL
,	NULL
Nicola	NULL
NA	NULL
,	NULL
Hilton	NULL
DJ	NULL
:	NULL
A	NULL
family	NULL
of	NULL
cytokine-inducible	NULL
inhibitors	NULL
of	NULL
signalling	NULL
.	NULL

Nature	NULL
387:917	NULL
,	NULL
1997	NULL
37	NULL
.	NULL

Naka	NULL
T	NULL
,	NULL
Narazaki	NULL
M	NULL
,	NULL
Hirata	NULL
M	NULL
,	NULL
Matsumoto	NULL
T	NULL
,	NULL
Minamoto	NULL
S	NULL
,	NULL
Aono	NULL
A	NULL
,	NULL
Nishimoto	NULL
N	NULL
,	NULL
Kajita	NULL
T	NULL
,	NULL
Taga	NULL
T	NULL
,	NULL
Yoshizaki	NULL
K	NULL
,	NULL
Akira	NULL
S	NULL
,	NULL
Kishimoto	NULL
T	NULL
:	NULL
Structure	NULL
and	NULL
function	NULL
of	NULL
a	NULL
new	NULL
STAT-induced	NULL
STAT	NULL
inhibitor	NULL
.	NULL

Nature	NULL
387:924	NULL
,	NULL
1997	NULL
38	NULL
.	NULL

Endo	NULL
TA	NULL
,	NULL
Masuhara	NULL
M	NULL
,	NULL
Yokouchi	NULL
M	NULL
,	NULL
Suzuki	NULL
R	NULL
,	NULL
Sakamoto	NULL
H	NULL
,	NULL
Mitsui	NULL
K	NULL
,	NULL
Matsumoto	NULL
A	NULL
,	NULL
Tanimura	NULL
S	NULL
,	NULL
Ohtsubo	NULL
M	NULL
,	NULL
Misawa	NULL
H	NULL
,	NULL
Miyazaki	NULL
T	NULL
,	NULL
Leonor	NULL
N	NULL
,	NULL
Taniguchi	NULL
T	NULL
,	NULL
Fujita	NULL
T	NULL
,	NULL
Kanakura	NULL
Y	NULL
,	NULL
Komiya	NULL
S	NULL
,	NULL
Yoshimura	NULL
A	NULL
:	NULL
A	NULL
new	NULL
protein	NULL
containing	NULL
an	NULL
SH2	NULL
domain	NULL
that	NULL
inhibits	NULL
JAK	NULL
kinases	NULL
.	NULL

Nature	NULL
387:921	NULL
,	NULL
1997	NULL
39	NULL
.	NULL

Matsumoto	NULL
A	NULL
,	NULL
Masuhara	NULL
M	NULL
,	NULL
Mitsui	NULL
K	NULL
,	NULL
Yokouchi	NULL
M	NULL
,	NULL
Ohtsubo	NULL
M	NULL
,	NULL
Misawa	NULL
H	NULL
,	NULL
Miyajima	NULL
A	NULL
,	NULL
Yoshimura	NULL
A	NULL
:	NULL
CIS	NULL
,	NULL
a	NULL
cytokine	NULL
inducible	NULL
SH2	NULL
protein	NULL
,	NULL
is	NULL
a	NULL
target	NULL
of	NULL
the	NULL
JAK-STATS	NULL
pathway	NULL
and	NULL
modulates	NULL
STATS	NULL
activation	NULL
.	NULL

Blood	NULL
89:3148	NULL
,	NULL
1997	NULL
40	NULL
.	NULL

Gazzinelli	NULL
RT	NULL
,	NULL
Oswald	NULL
IP	NULL
,	NULL
James	NULL
SL	NULL
,	NULL
Sher	NULL
A	NULL
:	NULL
IL-10	NULL
inhibits	NULL
parasite	NULL
killing	NULL
and	NULL
nitric	NULL
oxide	NULL
production	NULL
by	NULL
IFN-y-activated	NULL
macro-phages	NULL
.	NULL

J	NULL
Immunol	NULL
148:1792	NULL
,	NULL
1992	NULL
41	NULL
.	NULL

O'Garra	NULL
A	NULL
,	NULL
Murphy	NULL
K	NULL
:	NULL
Role	NULL
of	NULL
cytokines	NULL
in	NULL
determining	NULL
T-lymphocyte	NULL
function	NULL
.	NULL

Curr	NULL
Opin	NULL
Immunol	NULL
6:458	NULL
,	NULL
1994	NULL
42	NULL
.	NULL

Moore	NULL
KW	NULL
,	NULL
O'Garra	NULL
A	NULL
,	NULL
de	NULL
Waal	NULL
Malefyt	NULL
R	NULL
,	NULL
Vieira	NULL
P	NULL
,	NULL
Mosmann	NULL
TR	NULL
:	NULL
Interleukin-10	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
11:165	NULL
,	NULL
1993	NULL
43	NULL
.	NULL

Lehmann	NULL
J	NULL
,	NULL
Seegert	NULL
D	NULL
,	NULL
Strehlow	NULL
I	NULL
,	NULL
Schindler	NULL
C	NULL
,	NULL
Lohmann-Matthes	NULL
M-L	NULL
,	NULL
Decker	NULL
T	NULL
:	NULL
IL-10-induced	NULL
factors	NULL
belonging	NULL
to	NULL
the	NULL
p91	NULL
family	NULL
of	NULL
proteins	NULL
bind	NULL
to	NULL
IFN-y-responsive	NULL
promoter	NULL
elements	NULL
.	NULL

J	NULL
Immunol	NULL
153:165	NULL
,	NULL
1994	NULL
44	NULL
.	NULL

Wehinger	NULL
J	NULL
,	NULL
Gouilleux	NULL
G	NULL
,	NULL
Groner	NULL
B	NULL
,	NULL
Finke	NULL
J	NULL
,	NULL
Mertelsmann	NULL
R	NULL
,	NULL
Weber-Nordt	NULL
RM	NULL
:	NULL
IL-10	NULL
induces	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
three	NULL
STAT	NULL
proteins	NULL
(	NULL
Statl	NULL
,	NULL
Stat3	NULL
,	NULL
and	NULL
Stat5	NULL
)	NULL
and	NULL
their	NULL
distinct	NULL
combinatorial	NULL
assembly	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
selected	NULL
genes	NULL
.	NULL

FEBS	NULL
Lett	NULL
394:365	NULL
,	NULL
1996	NULL
45	NULL
.	NULL

Adams	NULL
TE	NULL
,	NULL
Hansen	NULL
JA	NULL
,	NULL
Starr	NULL
R	NULL
,	NULL
Nicola	NULL
NA	NULL
,	NULL
Hilton	NULL
DJ	NULL
,	NULL
Billestrup	NULL
N	NULL
:	NULL
Growth	NULL
hormone	NULL
preferentially	NULL
induces	NULL
the	NULL
rapid	NULL
,	NULL
transient	NULL
expression	NULL
of	NULL
SOCS-3	NULL
,	NULL
a	NULL
novel	NULL
inhibitor	NULL
of	NULL
cytokine	NULL
receptor	NULL
signalling	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
273:1285	NULL
,	NULL
1998	NULL
46	NULL
.	NULL

Klingmuller	NULL
U	NULL
,	NULL
Lorenz	NULL
U	NULL
,	NULL
Cantley	NULL
LC	NULL
,	NULL
Neel	NULL
BG	NULL
,	NULL
Lodish	NULL
HF	NULL
:	NULL
Specific	NULL
recruitment	NULL
of	NULL
SH-PTPI1	NULL
to	NULL
the	NULL
erythropoietin	NULL
receptor	NULL
causes	NULL
inactivation	NULL
of	NULL
Jak2	NULL
and	NULL
termination	NULL
of	NULL
proliferative	NULL
signals	NULL
.	NULL

Cell	NULL
80:729	NULL
,	NULL
1995	NULL
47	NULL
.	NULL

Pawson	NULL
T	NULL
:	NULL
Protein	NULL
modules	NULL
and	NULL
signalling	NULL
networks	NULL
.	NULL

Nature	NULL
373:573	NULL
,	NULL
1995	NULL
48	NULL
.	NULL

Sims	NULL
SH	NULL
,	NULL
Cha	NULL
Y	NULL
,	NULL
Romine	NULL
MF	NULL
,	NULL
Gao	NULL
P-Q	NULL
,	NULL
Gottlieb	NULL
K	NULL
,	NULL
Deisseroth	NULL
AB	NULL
:	NULL
A	NULL
novel	NULL
interferon-inducible	NULL
domain	NULL
:	NULL
Structural	NULL
and	NULL
functional	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
interferon	NULL
regulatory	NULL
factor	NULL
1	NULL
gene	NULL
promoter	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:690	NULL
,	NULL
1993	NULL
49	NULL
.	NULL

Kumar	NULL
A	NULL
,	NULL
Yang	NULL
YL	NULL
,	NULL
Flati	NULL
V	NULL
,	NULL
Der	NULL
S	NULL
,	NULL
Kadereit	NULL
S	NULL
,	NULL
Deb	NULL
A	NULL
,	NULL
Haque	NULL
J	NULL
,	NULL
Reis	NULL
L	NULL
,	NULL
Weissmann	NULL
C	NULL
,	NULL
Williams	NULL
BR	NULL
:	NULL
Deficient	NULL
cytokine	NULL
signaling	NULL
in	NULL
mouse	NULL
embryo	NULL
fibroblasts	NULL
with	NULL
a	NULL
targeted	NULL
deletion	NULL
in	NULL
the	NULL
PKR	NULL
gene	NULL
:	NULL
Role	NULL
of	NULL
IRF-1	NULL
and	NULL
NF-kappaB	NULL
.	NULL

EMBO	NULL
J	NULL
15:406	NULL
,	NULL
1997	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1999	NULL
93	NULL
:	NULL
1456-1463	NULL
Interleukin-10	NULL
Inhibits	NULL
Expression	NULL
of	NULL
Both	NULL
Interferon	NULL
?	NULL

-	NULL
and	NULL
Interferon	NULL
y-Induced	NULL
Genes	NULL
by	NULL
Suppressing	NULL
Tyrosine	NULL
Phosphorylation	NULL
of	NULL
STATA	NULL
Satoshi	NULL
Ito	NULL
,	NULL
Parswa	NULL
Ansari	NULL
,	NULL
Minoru	NULL
Sakatsume	NULL
,	NULL
Harold	NULL
Dickensheets	NULL
,	NULL
Nancy	NULL
Vazquez	NULL
,	NULL
Raymond	NULL
P.	NULL
Donnelly	NULL
,	NULL
Andrew	NULL
C.	NULL
Larner	NULL
and	NULL
David	NULL
S.	NULL
Finbloom	NULL
4	NULL
QM	NULL
“	NULL
Caw	NULL
,	NULL
.	NULL

,	NULL
'	NULL
\se	NULL
@	NULL
.	NULL

2	NULL
YOtow®	NULL
@	NULL
207	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/93/5/1456.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Focus	NULL
on	NULL
Hematology	NULL
(	NULL
29	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

